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The turnover and maintenance of myelin in the adult CNS 
Myelin is a multilayered membrane structure generated by oligodendrocytes in the CNS that 
insulates and supports axons. While most of the oligodendrocyte population differentiates 
early in life and persist for most of the lifetime, myelin proteins are slowly turned over and 
replaced within weeks to months. However, the mechanisms of this turnover and 
replacement processes within the myelin sheath are largely unknown. One reason is the 
absence of a suitable model system. To study myelin turnover in the adult animal a model 
system is required that allows to investigate myelin maintenance under conditions of 
ongoing turnover, survival of oligodendrocytes and the avoidance of acute inflammation. In 
this thesis a new model system was established that meets these requirements and was 
used to study turnover within the individual myelin sheath. This model system is based on 
a strategy for the visualization of myelin renewal by the application of an inducible deletion 
of myelin basic protein (Mbp) expression in the adult. For this purpose, ablation of MBP was 
induced in young adult mice after completion of developmental myelination at the age of 8 
weeks. After the knock-out was induced, any newly synthetized myelin membrane lacked 
MBP and therefore the essential component for myelin compaction. The absence of 
compaction served as a marker for newly made myelin and was studied by electron 
microscopy. Using volume imaging by focused ion beam scanning electron microscopy (FIB-
SEM) we observed the emergence of non-compact myelin membranes at the inner tongue 
of the juxta-paranodal region. The localized emergence of these membranes suggests the 
juxta-paranode as a site of MBP integration within the myelin sheath. Furthermore, the 
progressive loss of compact myelin after ablation of MBP synthesis was quantified and a 
shortening of internodes in the optic nerve by 50% within 19-21 weeks was observed. This 
shows that under these conditions half of the internode is turned over within 4-5 months. 
We performed proteome analysis of the optic nerve eight, 16 and 40 weeks after Mbp knock-
out induction to investigate systemic responses after loss of de novo MBP synthesis and 
found reduced abundance for proteins associated to the myelin sheath and cell adhesion 
molecules while many cytoskeleton-associated proteins were increased in abundance. 
These results are in accordance with the detected loss of the compact myelin compartment. 
To identify potential mechanisms for oligodendrocyte intrinsic or extrinsic recycling of 
myelin we analyzed individual axons in 3D FIB-SEM volumes and detected an increased 
number of myelin spheres at the inner tongue of the oligodendrocytes. We suggest that 
these myelin spheres are very likely involved in disposal of aged myelin. Visualization of the 
observed processes of membrane integration and removal were made possible by 
combination of high-quality structural preservation, 3D FIB-SEM microscopy and the novel 
mouse model system. In conclusion, this study introduced and characterized a powerful tool 
to study myelin maintenance and turnover and used this to shed light on the process of 
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Chapter 1 Introduction 
1.1 Glia cells in the central nervous system 
The central nervous system (CNS) controls essential functions of the body and mind 
including the coordination of movement, regulating body functions such as heart rate, 
release of hormones and even more complex tasks like learning and memory. The 
mammalian central nervous system is composed of the brain and the spinal cord and is 
made up of a variety of cell types mainly divided into neurons and glia. While neurons 
generate, transmit and integrate information via changes in electrical potential, glial cells 
create the necessary framework and infrastructure for neurons to function. They are mainly 
divided in astrocytes, microglia and oligodendrocytes. Glial cells are essentially involved in 
all brain functions and are approximately as numerous as neurons in the human CNS (Allen 
and Barres, 2009; von Bartheld et al., 2016) with recent estimates suggesting that in human 
neocortex approximately 75% of glial cells are oligodendrocytes, 5% microglia and 20% are 
astrocytes (Pelvig et al., 2008; Butt and Verkhratsky, 2013) Astrocytes enclose endothelial 
cells, provide trophic support for other cell types, maintaining the homeostasis of water and 
ions in the brain (Kandel et al., 2012), contact and enclose synapses with their fine 
perisynaptic processes (Allen and Eroglu, 2017) and are involved in synaptic recycling 
(Allen and Barres, 2009). Microglia are the resident immune and inflammatory cells of the 
CNS and its primary defense against pathogens. They are involved in recycling of dead cells, 
pruning of synapses (Kandel et al., 2012) and the uptake of myelin (Safaiyan et al., 2016). A 
third branch of glial cells are the myelin forming oligodendrocytes. In vertebrates, the 
conduction of electrical signals along axons is accelerated through the formation of a 
multilamellar, lipid rich structure called myelin. The maintenance and turnover of myelin 
in the CNS of adult mice will be the main focus of this thesis.  
 
1.2 Myelin insulates axons and accelerates signal transduction 
Myelin, the insulating material of the nervous system, was first described by Rudolf Virchow 
in the early 19th century. He found myelin in tissue sections and described it as “nerve glue” 
that is providing stability and support for surrounding nerve cells (Virchow, 1854; 
Boullerne, 2016). Myelin evolved around 500 million years ago in cartilaginous fish as a new 
development of the vertebrate lineage (Zalc et al., 2008) and to date it is present in all living 
vertebrate species (Nawaz et al., 2013). Vertebrate myelin is a specialized multi-layered and 
lipid rich membrane that can be found in the peripheral nervous system where it is 
generated by Schwann cells and in the central nervous system where it is formed by 
oligodendrocytes. It provides several key advantages that might explain its success in the 
vertebrate lineage. The ensheathment of an axon by a multilayered myelin sheath allows a 
10 - fold increase in conduction speed by saltatory signal propagation (Hartline and Colman, 
2007). The insulation and increase in conduction speed allows for smaller axonal diameters 
(Baumann and Pham-Dinh, 2001), up to a 1000-fold lower energy consumption and higher 
signal fidelity compared to unmyelinated axons with similar conduction speed (Hartline 




Oligodendrocytes, beside astrocytes, also provide metabolites for axonal energy production 
(Pellerin and Magistretti, 1994; Fünfschilling et al., 2012; Lee et al., 2012). The total length 
of an axon can be up to 1 meter and mitochondria occupy a relative constant percentage of 
1.5% of axonal volume. This suggests a correlation between axonal diameter and energy 
requirements (Perge et al., 2009). The generation of large amounts of ATP in these 
mitochondria is required to maintain the axonal membrane potential by the activity of the 
Na+/K+-ATPase (Almeida et al., 2001; Saez et al., 2014; Philips and Rothstein, 2017). Since 
neurons have high metabolic demand and low energy storage capacity in their long 
processes they are partly dependent on astrocytes and oligodendrocytes to generate the 
required amount of energy for restoration of the membrane potential (Philips and 
Rothstein, 2017). This observation is supported by experiments from Fünfschilling and 
colleagues who have suggested lactate as a possible metabolite in support of axons 
(Fünfschilling et al., 2012). The transfer of metabolites between oligodendrocyte and axon 
is mediated by the shuttling of lactate and pyruvate by monocarboxylate transporters 
located in the paranodal myelin (Saab et al., 2016). The provided lactate is then converted 
into pyruvate by neuronal lactate dehydrogenase and can enter the tricarboxylic acid (TCA) 
cycle to be used for axonal ATP synthesis (Fünfschilling et al., 2012; Lee et al., 2012; Saab et 
al., 2013). The lack of support by oligodendrocytes and a disturbed axon-glia unit are likely 
contributors to multiple sclerosis and amyotrophic lateral sclerosis where neurons are 
metabolically stressed emphasizing the importance of metabolic support for the 
maintenance of axonal health (Campbell and Mahad, 2014; Philips and Rothstein, 2017).  
 
1.3 Myelin structure and composition 
On ultrastructural level, as observed by electron microscopy, the myelin sheath (Figure 1-1) 
is a multilayered structure with alternating electron lucent and electron dense layers with 
a periodicity of 12 nm (Baumann and Pham-Dinh, 2001). The electron lucent layer is the 
intraperiod line formed by compaction of the outer myelin membrane layers by proteolipid 
protein (PLP). The darker layer is the major dense line that is formed by myelin basic 
protein (MBP) which compacts the cytosolic inner leaflets of the myelin membrane (Morell 
and Quarles, 1999). The thickness of the myelin sheath is dependent on the axonal diameter 
and can be described as the ratio between the axonal diameter divided by the diameter of 
the fiber including the myelin sheath. This parameter is called g-ratio and a range between 
0.6 to 0.7 has been found to ensure optimal insulation (Rushton, 1951; Morell and Quarles, 
1999; Hartline and Colman, 2007).  
Myelin is divided into two compartments with specific molecular compositions: Non-
compact and compact myelin. Non compact myelin contains cytoplasm and proteins like 
myelin-associated glycoprotein (MAG), or 2',3'-cyclic nucleotide 3'-phosphodiesterase 
(CNP), cytoskeletal elements like actin, tubulin or septins and organelles such as 
mitochondria, peroxisomes and vesicles (Aggarwal et al., 2011b; Patzig et al., 2016; Rinholm 
et al., 2016). The non-compact myelin compartment, namely the inner and outer tongue as 
well as cytoplasmic channels within the myelin sheath connect the oligodendrocyte to its 







Figure 1-1: Cross section of an axon in the optic nerve  
The retinal ganglion cell axon is wrapped by several layers of compact myelin with a dark major dense line and 
a lighter intraperiod line. The oligodendrocyte is in contact with its myelin compartment via non-compacted 
myelin areas such as the inner and outer tongue and the cytoplasmic channels. TEM Micrograph, High pressure 
frozen and freeze substituted optic nerve, scale bar 200 nm. 
 
Myelin membrane is composed of 70-80% lipids and 20-30% proteins having a high lipid 
content compared to other plasma membranes which mostly have equal ratio of lipids and 
proteins (Norton and Autili, 1965; Pfeiffer et al., 1993). The most abundant lipids in rodent 
myelin are cholesterol (27%), galactosylcerebroside (GalC) (24%) and ethanolamine-
containing plasmalogens (14%)  with GalC being the most typical myelin lipid as its amount 
is directly proportional to the amount of myelin in the brain (Morell and Quarles, 1999). 
Ablation of the synthesis of certain lipid classes is influencing myelination as for example 
the biosynthesis of cholesterol which is rate limiting for myelin biogenesis (Saher et al., 
2005, 2009). In contrast GalC synthesis by UDP glycosyltransferase 8 (ugt8a) is not required 
for the formation of myelin membrane but the formation of the node of Ranvier. In the 
absence of GalC, mice have normal appearing compact myelin but develop hindlimb 
paralysis and extensive myelin vacuolation suggesting that GalC might have a role in myelin 
maintenance (Coetzee et al., 1996; Dupree et al., 1998). 
Major proteins of the myelin sheath include proteolipid protein (PLP), myelin 
oligodendrocyte glycoprotein (MOG), myelin-associated glycoprotein (MAG), 2',3'-cyclic 
nucleotide 3'-phosphodiesterase (CNP) and myelin basic protein (MBP). 
Proteolipid protein (PLP), the most abundant myelin protein (17%) (Jahn et al., 2009), 
belongs to the tetraspanin protein family and stabilizes the intraperiod line in compact 
myelin. Mice with ablated PLP have a compact myelin sheath with a condensed intraperiod 
line but develop axonal swellings and degeneration within the first year of  life (Griffiths et 
al., 1998; Lüders et al., 2017). The ablation of PLP in adult animals after completion of 
myelination results in axonal pathology (Griffiths et al., 1998). This suggests that its ongoing 
presence is required for the maintenance of axonal support by oligodendrocytes (Lüders et 
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al., 2019). The importance of PLP as a myelin component is reflected by different diseases 
which are associated either with mutations or overexpression such as in different forms of 
Pelizaeus-Merzbacher disease or are caused by the lack of PLP as in X-linked spastic 
paraplegia type 2 (Hobson and Kamholz, 1993; Yool et al., 2000) 
Myelin oligodendrocyte glycoprotein (MOG) is a glycoprotein expressed on the 
oligodendrocyte cell surface and the outer tongue of the myelin sheath (Brunner et al., 
1989). Due to its exposed location and high accessibility to immune cells it is frequently 
used as an autoantigen in immune mediated models of multiple sclerosis (Berger and 
Reindl, 2000; Iglesias et al., 2001; Pöllinger et al., 2009). The exact biological function of 
MOG is unknown but it is suggested to have adhesive function and to interact with the 
cytoskeleton to regulate stability of microtubules (Dyer et al., 1994; Johns and Bernard, 
1999) 
Myelin-associated glycoprotein (MAG) is a type I transmembrane glycoprotein that binds 
to gangliosides thereby maintaining the myelin-axon spacing  (Pronker et al., 2016). It has 
adhesive functions and is primarily localized to adaxonal myelin. MAG is found in the 
periaxonal space along the myelin internode and implicated in axo-glial interaction, initial 
adhesion during myelination and signal transduction through Fyn kinase (Umemori et al., 
1994; Schnaar et al., 1998; Quarles, 2007). MAG knock-out mice exhibit delayed 
myelination, disrupted periaxonal space and progressive axonal degeneration (Li et al., 
1994; Yin et al., 1998). An interesting function of MAG in the PNS is the modulation of the 
axonal size. Decreased axonal caliber and reduced neurofilament spacing in PNS axons can 
be observed upon MAG knock-out (Yin et al., 1998).  
2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) is an enzyme localized in all parts of 
the non-compact myelin including inner and outer tongue, cytoplasmic myelin channels and 
the lateral loops (Vogel et al., 1988; Snaidero et al., 2014). It is expressed early in 
oligodendrocyte maturation and is known to bind to the cytoskeleton and implicated in 
axonal survival (Lappe-Siefke et al., 2003). Recent studies have linked CNP to the 
maintenance and formation of cytosolic channels in myelin. CNP is promoting actin 
assembly by opening of cytosolic channels in myelin thereby functioning as an antagonist 
to myelin compaction (Snaidero et al., 2017)  
 
1.4 Myelin basic protein acts as molecular zipper of CNS myelin  
1.4.1 Myelin Compaction  
By accounting for 8% of the myelin protein content MBP is the second most abundant CNS 
myelin protein after PLP and required for the formation of compact myelin (Vassall et al., 
2015). It is an intrinsically unstructured protein with a strong positive charge of +19 at 
physiological pH and a high degree of random coils (Hill et al., 2002). Through its high 
positive charge it interacts electrostatically with negatively charged lipids in the plasma 
membrane such as phosphatidyl serine and PIP2 (Boggs et al., 1977). Computational 
modeling based on small angle X-ray scattering (Ridsdale et al., 1997) suggests that MBP 
folds into a C shape upon interaction with opposing negatively charged lipid membranes 
(Raasakka et al., 2017). This conformational change enables its adhesive function and  
allows the self-activation of MBP and in turn triggers the formation of an MBP network 
(Figure 1-2) (Vassall et al., 2015). This network brings myelin membranes in close 
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apposition in a zipper like way and forms a molecular sieve that extrudes cytoplasm and 
membrane bound proteins with more then 20-30 amino acids independent of their charge 
from the compact myelin (Aggarwal et al., 2011b). Upon compaction, MBP is thought to be 
the main constituent of the major dense line (Mizuhira and Ozawa, 1967; Min et al., 2009). 
 
 
Unfolded MBP is inserted into nascent myelin membrane and binds to the negatively charged cytoplasmic leaflet 
dominated by phospholipids through electrostatic interaction. Upon binding, MBP is partially integrated into 
the leaflet and changing its conformational state upon binding of negatively charged lipid. Once a critical 
threshold of MBP molecules is reached it adheres to the second cytoplasmic leaflet and folds into its adhesive C 
shape and forms the major dense line by extruding the cytoplasm. Adapted from Raasakka et al., 2017. 
 
Other known functions of MBP are associated with interaction partners such as calcium 
dependent binding to calmodulin, a highly acidic calcium sensor (Libich and Harauz, 2008; 
Majava et al., 2010) and the interaction with cytoskeletal elements such as actin and tubulin 
(Harauz and Libich, 2009; Bamm et al., 2011). During myelination MBP is also involved in 
actin disassembly while CNP has been shown to promote actin assembly (Aggarwal et al., 
2011b; Zuchero et al., 2015; Snaidero et al., 2017). This interplay between MBP and CNP is 
involved in the formation of non-compact cytosolic channels within the compact myelin 
which are suggested to be a transfer route for metabolites and signaling molecules 
(Snaidero et al., 2014, 2017).  
  
Figure 1-2 Assembly of the major dense line upon formation of compact myelin 
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1.4.2 Transcription and Translation of MBP  
The MBP gene encodes two different families of proteins: the Golli MBP isoforms (GOLLI: 
genes of the oligodendrocyte lineage) and the classical MBP isoforms localized in myelin. 
Golli MBP isoforms encode three proteins named BG21, J37 and TP8 which localize to the 
oligodendrocyte nucleus (Reyes and Campagnoni, 2002). These isoforms are expressed 
during intermediate stages of oligodendrocyte maturation and seems to be involved in the 
calcium homeostasis and membrane elaboration of oligodendrocytes during myelination 
(Campagnoni et al., 1993; Paez et al., 2007) Golli MBP isoforms are not specific to 
oligodendrocytes but are also expressed in neurons in the CNS and PNS (Landry et al., 1997) 
and in cells of the immune system such as macrophages or B cells with unknown function 
(Pribyl et al., 1993).  
In mice six classic MBP isoforms are expressed (21.5, 20.2, 18.5, 17.24, 17.22 and 14 kDa) 
of which the 14 and 18.5 kDa isoforms represent with 70% the majority of the transcripts 
(Barbarese et al., 1977; Akiyama et al., 2002). The 14 and 18 kDa isoforms are known to 
have a high membrane affinity and are expressed late in myelination as they are required 
for myelin compaction. Expression of the 14 kDa isoform alone is sufficient to rescue 
myelination in shiverer mice (Kimura et al., 1989). In contrast, the less abundant isoforms 
17 kDa and 21.5 kDa localize to the nucleus of young oligodendrocytes suggesting a 
potential regulatory role in myelination (Allinquant et al., 1991; Pedraza, 1997). While MBP 
is highly conserved on a genetic level, the isoform profile in human CNS is slightly different 
with the following isoforms being expressed 21.5, 20.2, 18.5, 17.24, 17.22 kDa of which the 
18 kDa isoform is most abundant (Kamholz et al., 1986). MBP is also present in the PNS 
myelin but it is not required for peripheral myelination (Kirschner and Ganser, 1980). In 
the PNS the adhesive function for myelin compaction is facilitated by myelin protein P0 
(Sakamoto et al., 1987; Martini et al., 1995) and potentially also by PMP22 (Suresh et al., 
2010; Ruskamo et al., 2014) 
In oligodendrocytes myelin associated MBP isoforms are not translated in the soma. Instead 
MBP mRNA is bound in RNA granules and targeted by its 3'UTR (untranslated region) to the 
plasma membrane and into myelinating processes and are enriched in the myelin fraction 
(Colman et al., 1982; Kristensson et al., 1986; Torvund-Jensen et al., 2018). Translation is 
triggered by phosphorylation of ribonucleoprotein A2 by Fyn kinase resulting in strictly 
controlled local MBP mRNA translation at sites of membrane compaction (White et al., 
2008; Torvund-Jensen et al., 2014) 
 
1.4.3 Role of MBP in human diseases  
During its lifetime MBP can undergo a large number of post-translational modifications 
including phosphorylation, citrullination/deimination (modification of arginine to 
citrulline), deamidation (modification of an amide), acylation (addition of an acyl group) 
and arginine methylation (addition of an methyl group) (Zhang et al., 2012). These 
modifications can lower the charge of MBP resulting in decreased membrane adhesion and 
changes in functional properties. Modifications like acetylation and citrullination of MBP 
can even provoke an immune reaction (Zamvil et al., 1986; Cao et al., 1999). The strong 
positive charge of MBP of +19 is reduced by 1 for every added citrullinated arginine 
suggesting that citrullination can play a role in myelin decompaction and demyelinating 
diseases by lowering the binding affinity of MBP to membranes. This is supported by in vitro 
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experiments where high levels of MBP citrullination have been shown to perturb membrane 
stacking and in vivo evidence for increased MBP citrullination after demyelination by mild 
cuprizone treatment (Beniac et al., 2000; Caprariello et al., 2018). The level of highly 
citrullinated MBP is increased 2-3 fold in chronic MS patients (Moscarello et al., 1994) and 
citrullinated MBP was found to be ten times more susceptible to cathepsin D degradation 
compared to non-citrullinated MBP (Cao et al., 1999). Up to 90 % of MBP in Marburg 
syndrome patients and up to 45% of MBP in chronic MS patients is highly citrullinated 
compared to 20% in healthy brains (Ridsdale et al., 1997) supporting a role for citrullination 
in demyelinating diseases.  
In contrast to PLP, where several mutations are known to cause severe neurological defects 
like Pelizaeus-Merzbacher disease (PMD) or spastic paraplegia type 2 (SPG2) (Hobson and 
Kamholz, 1993), there is little evidence for human diseases associated with MBP mutation 
or loss. In humans MBP is localized to chromosome 18 position 18q23. Deletion of this part 
of chromosome 18, called 18q- syndrome or De-Grouchy-Syndrome is a rare partial 
monosomy that renders patients haploinsufficient for MBP. While the chromosomal 
deletion affects many genes the loss of MBP is considered to be responsible for delayed 
myelination and myelin defects in these patients as observed by magnetic resonance 
imaging (Ono et al., 1994; Arguedas and Batchelor, 2009). However, there is one reported 
case where a verified MBP haploinsufficiency does not result in an obvious loss of compact 
myelin despite abnormal MRI signals (Tanaka et al., 2012). 
While no monogenetic disease is associated with loss of MBP its abundance is affected in 
some neurological disorders. Patients with schizophrenia or bipolar disorders have reduced 
levels of MBP in the frontal and temporal lobe and the entorhinal cortex (Chambers and 
Perrone-Bizzozero, 2004; Parlapani et al., 2009). The relevance of reduced MBP levels in 
the cortex is supported by Poggi and colleagues (Poggi et al., 2016). In their study mice 
heterozygous for MBP showed mostly normal behavior but were mildly hypomyelinated 
and had a low-grade inflammation in the prefrontal cortex. Interestingly, MBP 
heterozygosity led to subtle effects on sensorimotor gating in form of reduced prepulse-
inhibition and late-onset catatonia which hints towards a cortical network dysfunction 





Oligodendrocytes from shiver mice are not able to form mature compact myelin membrane. Despite the lack of 
MBP, oligodendroglia ensheathment takes place but is not sufficient to maintain axonal insulation. TEM 
micrograph of High pressure frozen optic nerve at the age of 10 weeks.  
 
1.5 The shiverer mouse – A naturally occurring MBP mutant  
A naturally occurring mouse mutant for MBP called shiverer was described in 1977 
(Doolittle and Schweikart, 1977; Chernoff, 1981). Shiverer mice have an autosomal 
recessive deletion of exon 2 to 7 of the classical MBP locus and are unable to form compact 
myelin. These mice begin to shiver at the end of the second postnatal week, the peak of 
myelination. During the following weeks shiverer mice develop a progressively increasing 
tremor, tonic convulsions and seizures before they die prematurely at an age of 8 - 11 weeks 
(Chernoff, 1981). Shiverer CNS has very little myelin that appears compact but lacks the 
major dense line. Instead non-compacted oligodendrocyte processes are present. 
Despite the lack of MBP, the initial wrapping of myelin takes place with likely support by 
the adhesive function of other myelin proteins like PLP and MAG, resulting in non-compact 
myelin membranes wrapping axons (Stoffel et al., 1997) (Figure 1-3). While many MBP 
isoforms exist, the expression of the 14 kDA classical MBP isoform is sufficient to rescue 
myelination defects in shiverer, suggesting a certain functional redundancy between 
isoforms (Kimura et al., 1989). A second, naturally occurring MBP mouse mutant is the so-
called myelin deficient mouse (mld). These mice have an inversion of exon 2 in a duplicated 
MBP gene resulting in antisense RNA expression and reduced MBP mRNA and subsequently 
protein levels (Okano et al., 1987; Readhead and Hood, 1990) The shiverer phenotype could 
Figure 1-3 MBP is required for the formation of compact myelin 
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be recapitulated by generating mice expressing an antisense MBP construct (Katsuki et al., 
1988).  
The consequences of MBP knock-out are the almost complete loss of compact myelin and 
nodal structures as well as impaired nerve signal conduction. Decreased nerve conduction 
velocity in shiverer animals was measured in several white matter tracts and was reduced 
by 40% in spinal cord, by 20% in corpus callosum and by 60% in optic nerve (Rasband et 
al., 1999; Sinha et al., 2006; Windrem et al., 2008). Large caliber axons in shiverer mice show 
less focal sodium channel clustering (Rasband and Shrager, 2000) but increased overall 
sodium and potassium channel density suggesting a compensatory mechanism to preserve 
excitability in the absence of compact myelin (Noebels et al., 1991; Wang et al., 1995). 
Further changes observed in shiverer mice are decreased ganglioside and cholesterol 
content in CNS myelin (Bird et al., 1978; Uschkureit et al., 2000), increased proliferation of 
NG2+ cells (Bu et al., 2004) and increased enzymatic activity of cytochrome C oxidase 
implicating increased mitochondrial activity in spinal cord axons (Andrews et al., 2006).  
In contrast to the CNS shiverer, PNS myelin has normal periodic structure, sheath thickness 
and unchanged  conduction velocity (Privat et al., 1979; Uschkureit et al., 2000) Only minor 
alterations have been observed such as slight decompaction at the inner tongue and twice 
as many Schmidt-Lantermann incisures (Rosenbluth, 1980; Gould et al., 1995). 
Taken together the lack of MBP in shiverer mice results in severe CNS dysmyelination and 
axonal ion channels disorganization resulting in tremor, seizures and death within 10 weeks 
of age. Interestingly a double knock-out for PLP and MBP appears less affected, has more 
myelin layers and a longer lifetime, which led the authors to speculate that expression of 
PLP in the absence of MBP inhibits membrane wrapping around the axon (Stoffel et al., 
1997). 
 
1.6 Generation of the myelin sheath 
Myelination begins at the level of oligodendrocyte progenitor cells (OPC) that are derived 
from neural stem and progenitor cells during late embryonic development (Kessaris et al., 
2006). These cells are highly proliferative and migrate throughout the CNS. In mice 
formation of myelin begins at birth in the spinal cord and is mostly completed at postnatal 
day 60 by myelination of most brain regions (Baumann and Pham-Dinh, 2001). An essential 
part of this process is the synthesis of large amounts of protein and lipids. The formation of 
internodes happens in a matter of days and a single oligodendrocyte can produce up to 5000 
µm² myelin membrane with up to 160 membrane layers per day as shown in cat 
(Hildebrand et al., 1993, 1994; Pfeiffer et al., 1993). Through a staged maturation process 
(Figure 1-4) OPCs differentiate into premyelinating and then myelinating oligodendrocytes 
(Nave and Werner, 2014). OPCs reach out to an unmyelinated axon to form an OPC-axon 
contact and extend membrane processes towards the axon (Figure 1-4). The myelin sheath 
is divided into abaxonal myelin (outer part of the myelin sheath) and the adaxonal part of 
the myelin sheath, which is in close contact to the axon and comprises of the inner tongue. 
The nascent myelin sheath undergoes polarization mediated by PI(3,4,5)P3-dependent 
actin polymerization to form a growing edge followed by spiral extension of plasma 
membrane around the axon (Aggarwal et al., 2011a; Zuchero et al., 2015). By membrane 
trafficking towards the growing myelin sheath it undergoes lateral and radial expansion and 
new membrane is added at the inner tongue (Snaidero et al., 2014; Nawaz et al., 2015; 
Zuchero et al., 2015). In the abaxonal myelin MBP protein is synthesized and compaction 
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progresses mostly from the abaxonal to the adaxonal site with a delay of two to three myelin 
layers behind the leading edge (Hildebrand et al., 1994; Snaidero et al., 2014). The leading 
edge of the oligodendrocytes moves underneath the already present myelin layers and 
extends radially and longitudinally forming an internode (Snaidero et al., 2014).  
 
Following migration of the OPC to the site of myelin formation, the OPC extends processes to survey the 
surrounding for axons that require myelination. After contact establishment the nascent myelin sheath adheres 
to the axon and starts lateral and radial expansion to ensheath the target axon. During ensheathment the OPC 
matures into a myelinating oligodendrocyte and begins to express compact myelin markers. MBP protein is then 
locally translated and begins to compact myelin from the abaxonal to the adaxonal sheet. Modified from Nave 
and Werner, 2014. 
 
The lateral extension of the nascent myelin sheath and the covering of the axonal membrane 
induces the clustering of voltage gated sodium and potassium channels and formation of the 
node of Ranvier (Rasband and Peles, 2015). During lateral myelin sheath extension Na+ 
channels accumulate adjacent to the membrane processes. A node forms when Na+ channel 
accumulations from two adjacent myelin sheets fuse to form ion channel clusters. This is 
facilitated by glial derived extracellular matrix that clusters NF186, the formation of axon 
glial junctions as diffusion barrier and the axonal emergence of cytoskeletal scaffold 
proteins stabilizing the Na+ channels (Rasband et al., 1999; Susuki et al., 2013). 




Simplified illustration of adhesion proteins and ion channels in the axonal and oligodendrocyte membrane. 
(TEM micrograph: Node of Ranvier in an optic nerve longitudinal section).  
 
The nodal region (Figure 1-5) can be divided into distinct domains: the juxta-paranode, the 
paranodal axoglial junctions (paranode) and the node of Ranvier with its nodal gap. The 
node of Ranvier is characterized by the absence of myelin and the enriched localization of 
sodium (Na+) and potassium (K+) channel clusters required for rapid de- and repolarization 
of the axonal membrane during action potential conduction. Na+ channels including Nav1.1, 
Nav1.2 and Nav1.6 to Nav1.9 (Fjell et al., 2000; Boiko et al., 2001; Duflocq et al., 2008; 
Rasband and Peles, 2015) allow ion flux over the axonal membrane while the K+ channels 
including KCNC1, KCNQ2, and KCNQ3 regulate axonal excitability (Devaux et al., 2004; 
Battefeld et al., 2014; King et al., 2014). Beside the described channels required for axon 
potential propagation the node of Ranvier is enriched in specialized cytoskeletal elements 
such as ankyrin G and βIV-spectrin that are tethering the channels to the axonal 
cytoskeleton (Kordeli et al., 1995; Berghs et al., 2000). While the node is not covered by 
myelin some nodes are contacted by processes of perinodal astrocytes or oligodendrocyte 
precursors. These are suggested to buffer the perinodal extracellular ion concentration but 
the exact function remains to be investigated (Black and Waxman, 1988; Butt et al., 1994, 
1999).  
The node is directly flanked by the paranode, a specialized axonal glial contact site between 
axonal membrane and paranodal loops of the oligodendrocyte. Here, myelin lamellae form 
cytoplasmic spiraling loops that are connected to the axonal membrane by septate like 
junctions. The paranode is involved in the attachment of the myelin sheath to the axon and 
Figure 1-5 Molecular organization of Adhesion proteins at the node of Ranvier 
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the electric separation of node and internode (Rosenbluth, 2009). Adhesion proteins 
localized at the paranode are neurofilament 155 (NF155) on the site of the oligodendrocyte 
and its binding partners Caspr1 as well as contactin (CNTN) on the axonal membrane 
(Rasband and Peles, 2015).  
The juxta-paranode is covered by compact myelin and located between paranode and 
internode. Here, delayed rectifier potassium channels (Kv1.1 and Kv1.2) are expressed 
which are suggested to stabilize conduction and are involved in the maintenance of 
internodal resting potential during myelin formation (Chiu and Ritchie, 1980; Tao-Cheng 
and Rosenbluth, 1984; Arroyo et al., 2001; Chang and Rasband, 2013). Juxtaparanodal 
adherence is mediated by adhesion proteins TAG1 on the oligodendrocyte membrane and 
its respective partner CASPR2 and on the axonal membrane (Chang and Rasband, 2013). 
Axo-glia adhesion at the internode is achieved by the oligodendrocyte proteins MAG binding 
to axonal gangliosides and CADM4 binding CADM3 on the axonal side (Rasband and Peles, 
2015; Elazar et al., 2019). The correct assembly and maintenance of nodes of Ranvier is 
essential for signal conduction. Disruption of the node of Ranvier on the glial or the neuronal 
site for example during autoimmune neuropathies like Guillain-Barré syndrome, toxin 
ingestion (Isbister and Kiernan, 2005; Yuki and Hartung, 2012) or loss of nodal components 
(Dupree et al., 1998) results in impaired signal conduction or even conduction block 
(Susuki, 2013).  
 
1.7 Myelin Turnover – Half-life of myelin components  
1.7.1 Myelin protein half-life 
Once myelin has been generated and axonal wrapping is completed, myelin is considered 
mostly mature. This maturation is region-dependent. While most axons in the optic nerve 
are myelinated around postnatal day 60 (Biffiger et al., 2000), myelination is ongoing in the 
corpus callosum until at least postnatal day 120 (Waxman and Bennett, 1972; Remahl and 
Hildebrand, 1982; Yates and Juraska, 2007). Myelin that has been laid down by the 
oligodendrocyte and wrapped around an axon was for a long time considered stable and 
subject to little change.  
However, aged proteins need to be removed and replaced by de novo synthesis. This 
replenishment is required to provide accurate protein homeostasis and to prevent the 
accumulation of dysfunctional proteins. The determining factor of protein turnover is the 
half-life or half replacement time of proteins until they are degraded. While most proteins 
are exchanged relatively fast within hours or days, some have been found to be 
extraordinary stable (Sabri et al., 1974; Price et al., 2010; Savas et al., 2012; Toyama et al., 
2013; Fornasiero et al., 2018). Examples for very stable proteins with long half-lives are 
nucleosomes (Histone H2A up to 690 days), nuclear pore complexes (Nup188 h up to 67 
days) and especially myelin proteins (e.g. MOG up to 164 days) (Fornasiero et al., 2018). 
 
 
Studies from Sabri and colleagues in 1974 investigating the lifetime of individual myelin 
proteins found that compact myelin proteins like MBP and PLP had a high degree of 
“metabolic stability” (Sabri et al., 1974). However, with the given technical limitations they 
Introduction 
13 
were unable to accurately calculate the half-life of MBP and considered it to be very stable 
(Sabri et al., 1974). Recent studies have confirmed that some of the most long lived 
structures reside in the myelin fraction (Toyama et al., 2013; Fornasiero et al., 2018). With 
extensive mathematical modeling of amino acid re-utilization, more precise half-lives of 
long-lived proteins have been calculated. Myelin basic protein was found to have a half-life 
between 82 days in cortex, 101 days in cerebellum and 70 days in a long pulse chase 
experiment (described in Supplementary Table 1) (Fornasiero et al., 2018) but also other 
myelin proteins like PLP (80 days), Claudin11 (139 days) or MOG (164 days) show a very 
long half-life. Other myelin proteins that reside mostly in the non-compact myelin have 
shorter half-lives as for example CNP with about 53 and MAG with about 36 days. In 
summary, compared to the previously mentioned general protein half-life of 3 to 13 days 
the protein components of myelin are exceptionally stable. However, compact myelin is a 
tightly compacted membrane structure and proteins are probably entrapped in this 
compartment. The protein turnover rates in myelin might also be subject to changes. 
Disease or aging could influence the cellular maintenance machinery and change the 
turnover rate of certain components (Visscher et al., 2016). 
 
1.7.2 Myelin Lipid half-life 
Lipids within the myelin sheath show a high lateral mobility (Dawson and Gould, 1976) and 
the membrane fluidity is suggested to be dependent on its cholesterol content (Rosetti et 
al., 2008; Maxfield and van Meer, 2010). With over 25% total lipid content cholesterol is 
enriched two fold in myelin compared to other plasma membranes (van Meer et al., 2008) 
and its synthesis is rate limiting for myelination (Saher et al., 2005, 2009; Mathews et al., 
2014). Cholesterol has a very long half replacement time of 359 days in the myelin sheath 
of adult mice presumably being its most stable lipid (Ando et al., 2003; Saher et al., 2005). 
Half replacement times for other myelin lipids including cerebroside (94 days), ganglioside 
GM1 (102 days), phosphatidylethanolamine (25 days) and phosphatidylcholine (25 days) 
suggest that the lipids like the protein components of the myelin sheath are relatively stable 
but need to undergo turnover within months after myelination (Ando et al., 2003). The 
mechanism of removal and replacement of these lipids is unknown; the previously 
mentioned high lateral mobility of lipids within the sheet might allow continuous 
replacement through the soma of the oligodendrocyte.  
An interesting observation in the half replacement time of lipids as well as proteins is the 
occurrence of two pools with different turnover kinetics. Ando and colleagues concluded 
that in myelin of adult mice 60% of the lipids undergo rapid and 40% undergo slow 
exchange. For MBP it was also described that it has two pools with faster (21 days) and 
slower turnover (Sabri et al., 1974). It could be speculated that lipids and proteins have a 
certain half-replacement time directly after synthesis that is increasing as soon as they are 
integrated into larger stable structures like the myelin sheath.  
 
1.7.3 Oligodendrocyte half-life 
In rodents new oligodendrocytes are continuously generated during the adult life of an 
animal (Dimou et al., 2008; Rivers et al., 2008; Psachoulia et al., 2009; Kang et al., 2010; 
Tripathi et al., 2017). Despite the large number of cells generated, only very few of these 
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cells integrate into white matter tracts and form myelin sheaths (Young et al., 2013; Tripathi 
et al., 2017). Adult born oligodendrocytes that do integrate differ from developmentally 
born oligodendrocytes as they form more but shorter myelin sheets (Young et al., 2013) and 
especially after remyelination also thinner myelin (Harrison et al., 1972; Gledhill and 
McDonald, 1977; Duncan et al., 2017). Therefore, myelination in the adult CNS probably 
underlies different parameters compared to developmental myelination. 
Recent studies on the lifetime of oligodendrocytes in rodents show that oligodendrocytes 
survive for most of the life span of a mouse (Tripathi et al., 2017). The formation of new 
myelin and adult de novo myelination seems to be involved in learning of a motor task as 
shown by OPC proliferation and oligodendrocyte maturation (Young et al., 2013; McKenzie 
et al., 2014). Similar results have been obtained for the lifetime of oligodendrocytes in the 
human CNS. Based on two studies by Yeung and colleagues the majority of oligodendrocytes 
in the human CNS are formed until the age of 5 and survive up to 40 years (Yeung et al., 
2014, 2019). In contrast to rodents there seems to be no major proliferation of OPCs or 
oligodendrocytes during adulthood. Yeung and colleagues also investigated the age of 
oligodendrocytes in different multiple sclerosis lesions and found no signs of adult 
oligodendrogenesis in so called shadow plaques which are believed to be remyelinated 
lesions (Yeung et al., 2019). This finding supports the provocative idea that in the human 
CNS different to the rodent CNS, mature myelinated oligodendrocytes could be involved in 
and needed for remyelination (Jäkel et al., 2019; Yeung et al., 2019). 
The long life of oligodendrocytes and the lack of evidence for their replacement together 
with the described long but finite half-lives of myelin proteins and lipids raise the question 
of myelin maintenance in the adult animal. Protein and lipid turnover of adult myelin are 
required to maintain functionality of the myelin sheath. The previously mentioned studies 
found that, beside the long lifetime of the oligodendrocytes, the myelin compartment itself 
is turned over constantly (Toyama et al., 2013; Yeung et al., 2014; Fornasiero et al., 2018). 
Whether this necessary turnover is achieved by removal and replacement of whole myelin 





1.8 Myelin Degradation – Removal and recycling of myelin  
To maintain the structural integrity as well as plasticity of myelin internodes the CNS needs 
mechanisms to turnover aged and dysfunctional components without replacing the 
complete oligodendrocyte. This is especially true for the myelin compartment since the lipid 
rich membrane is relatively inert and challenging to recycle. It is not yet clear how 
dysfunctional proteins during steady state turnover gets removed from compacted myelin 
to enter the degradative system. Here, it is necessary to distinguish two distinct situations 
where myelin removal is required: The loss of myelin as a pathological process in a 
demyelinating disease state like in multiple sclerosis, neuromyelitis optica or other 
demyelinating diseases (Neumann et al., 2009; Clarner et al., 2012; Romanelli et al., 2016; 
Weil et al., 2016) and the removal of myelin components for intrinsic turnover and normal 
maintenance in an functional oligodendrocyte. The removal of myelin debris after disease 
or injury is mediated by several cell types. During a demyelinating process, myelin is taken 
up by microglia (Neumann et al., 2009; Romanelli et al., 2016), astrocytes (Morizawa et al., 




Microglial activation and expression of CD68 by sensing of myelin debris followed by Mac-2 mediated 
phagocytosis of myelin debris and formation of intracellular cholesterol crystals modified from Thériault and 
Rivest, 2016. 
 
The removal of myelin debris (Figure 1-6) is triggered by an inflammatory 
microenvironment and promotes the recruitment of microglia (Kotter et al., 2006; Napoli 
and Neumann, 2010). Uptake of myelin debris is required to reduce break down products 
and clear the environment from factors that are inhibitory for remyelination (Kotter et al., 
2006). Ineffective myelin debris clearance is partially responsible for the poor myelin 




regenerative ability in the CNS compared to the PNS making myelin removal an essential 
step in remyelination (Arandjelovic and Ravichandran, 2015). Microglial uptake of myelin 
debris is partially mediated via the TREM2 and the LRP1 receptor. Knock-out of TREM2 or 
LRP1 results in slowed myelin debris uptake and hinders remyelination (Gaultier et al., 
2009; Cantoni et al., 2015; Jay et al., 2015; Poliani et al., 2015). The capacity of microglia to 
take up and digest myelin is not unlimited. Upon phagocytosis of large amounts of myelin, 
as occurring in demyelinating lesion models, microglia can form intracellular cholesterol 
crystals to store excessive lipids and can be  visualized by electron microscopy (Cantuti-
Castelvetri et al., 2018). The catabolic conversion of myelin fragments to lipids and 
metabolites might support remyelination but it is so far unclear whether oligodendrocytes 
have direct access to the metabolites generated by myelin degradation (Cantuti-Castelvetri 
et al., 2018).  
The importance of microglia and also astrocytes for the clearance of myelin debris is well 
known (Kotter et al., 2006; Romanelli et al., 2016). However, it remains unclear whether 
and how microglia affect steady state myelin turnover in healthy myelin sheaths. Microglia 
actively take up myelin fragments released from aged myelin sheaths but this microglial 
myelin turnover is getting less effective with aging (Safaiyan et al., 2016). Uptake of myelin 
fragments, also called Marchi bodies (Hildebrand and Aldskogius, 1976; Persson and 
Berthold, 1991; Persson et al., 1992) or myelin spheres (Hill et al., 2018) were discussed as 
part of the turnover process (Persson and Berthold, 1991). How these myelin fragments are 
released or removed from the myelin sheath is yet unknown. However, oligodendrocytes, 
beside microglia and astrocytes also express LRP1 or degradation enzymes like Cathepsin 
D (Gaultier et al., 2009; Zhang et al., 2014) which might enable them to actively recycle 
myelin from their own myelin sheath.  
 
1.9 Models for Demyelination - myelin turnover  
Demyelinating diseases can be induced by external stimuli like toxins, viruses, traumata and 
by autoimmune reactions such as observed in diseases like multiple sclerosis or 
neuromyelitis optica. Furthermore, inherited defects such as Plp mutations in some forms 
of Pelizaeus-Merzbacher disease lead to demyelination (Hobson and Kamholz, 1993; Tan 
and Koralnik, 2010; Papadopoulos and Verkman, 2012; Graziano and Cardile, 2015). To 
understand these diseases different mouse models have been developed to study individual 
aspects of demyelinating conditions and different types of insults on the myelinating 
system. Experimental autoimmune encephalomyelitis (EAE) is used in mice to model 
autoimmune and inflammatory aspects of demyelination (Kornek et al., 2000). Paradigms 
to model toxin based demyelination are for example targeted injection of lysolecithin that 
disrupts myelin membranes (Plemel et al., 2018) or feeding of the chopper chelator 
cuprizone that leads to inhibition of mitochondrial complex IV, with selective toxicity for 
oligodendrocytes (Matsushima and Morell, 2001; Torkildsen et al., 2008). The advantage of 
these models is the fast demyelination ranging from weeks in EAE to days in cuprizone or 
lysolecithin models (Plemel et al., 2018) and the fast spontaneous remyelination within 
days to weeks as for example seen in the cuprizone model (Matsushima and Morell, 2001). 
Genetic models for demyelination include for example the targeted ablation of the myelin 
transcription factor myelin regulatory factor (MYRF) or the expression of the diphtheria 
toxin A subunit in adult oligodendrocytes (Traka et al., 2010; Koenning et al., 2012). 
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These fast and rather strong effects on the myelinating system makes them excellent models 
to study myelin breakdown as well as remyelination, but a central hallmark of these model 
systems is their strong effect on oligodendroglial health and survival. The loss of 
oligodendrocytes in these models makes them less suitable for the investigation of steady 
state myelin turnover and maintenance hence new models are required to study myelin 
turnover.  
 
1.10 Project Aim  
The turnover and maintenance of myelin are important elements of the oligodendrocyte 
homeostasis. Throughout the long lifetime of oligodendrocytes (Yeung et al., 2014; Tripathi 
et al., 2017) mechanisms are required to continuously replace myelin and its components. 
Turnover of myelin was so far investigated on protein level by determining half-lives of 
proteins found in the myelin fraction. These studies have shown that myelin proteins are 
especially long lived and are renewed in the range of weeks to months (Fornasiero et al., 
2018). However, little is known about the turnover of the adult myelin sheath itself as a 
structure. To investigate steady state myelin turnover a genetic model system is required 
that allows the visualization of turnover mechanisms under conditions of unperturbed 
myelin synthesis that avoids oligodendrocyte death and acute inflammation. Such a model 
will allow the characterization of homeostatic myelin renewal and replacement in a 
functional oligodendrocyte. For this study a genetic mouse model was developed that fulfils 
these criteria. In this thesis, I aim to investigate the site of myelin turnover within the myelin 
sheath. This will be approached by using the ablation of MBP synthesis in mature 
myelinating oligodendrocytes. The emergence of non-compact myelin membrane in the 
absence of MBP will be used to investigate sites of myelin component insertion into the 
mature myelin sheath. The detailed aims were:  
1) The characterization of the newly established inducible Mbp knock-out model regarding 
motor impairment, inflammation, oligodendrocyte survival and proliferation as well as 
myelin gene expression to validate it as a model to study myelin turnover. 2) The 
characterization of any structural changes as a consequence of the ablation of MBP de novo 
synthesis. 3) The localization of MBP-free non-compact myelin membranes within the 
myelin sheath using 3D focused ion beam scanning electron microscopy (FIB-SEM) of the 
optic nerve to investigate the sites of membrane integration in a mature myelin sheath. 
4) Characterization of the consequences of compact myelin loss in the optic nerve by 
proteome and lipid analysis as well as loss of axonal myelin coverage to estimate the half-
life of a myelin sheath after ablation of MBP synthesis. 5) The investigation of myelin 
removal processes within the myelin sheath using 3D FIB-SEM.  
To summarize, in this thesis I investigate the consequences of MBP synthesis ablation in 
mature oligodendrocytes as a tool to address aspects of myelin turnover and the 
maintenance of the compact myelin compartment. 
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Chapter 2 Material and Methods 
2.1 Material 
Chemicals were purchased from Sigma-Aldrich GMBP, Merck KGaA or SERVA unless stated 
otherwise. Laboratory plastic materials were purchased from BD-Falcon (Falcon tubes), 
Bio-rad (Western Blot equipment), Gilson and Eppendorf (Pipettes and Eppendorf cups) or 
Brand (Pipet tips)  
 
2.1.1 Generation of the mouse model  
To facilitate the ablation of MBP the flox mouse line (Mbpfl/fl, internal line nomenclature 
MBPFLX) was generated. Embryonic stem cells (ES) harboring a modified allele of the Mbp 
gene (Mbptm1a) were acquired from the European Conditional Mouse Mutagenesis Program 
(Eucomm). ES cells were microinjected into blastocysts derived from FVB mice and 
embryos were transferred to pseudopregnant foster mothers. For the ES clone B02 
(MBPFLX) germline transmission was achieved by breeding with C57BL/6N female mice. 
The resulting offspring harbored the Mbp-lacZ neo allel. The construct including the lacZ 
gene and a neomycin resistance cassette was excised by breeding to mice expressing a FLIP 
recombinase (129S4/SvJaeSor‐Gt(ROSA)26Sortm1(FLP1)Dym/J; backcrossed into 
C57BL/6N). The resulting offspring harbored an Mbp-flox allel in which exon 1 of the 
classical Mbp gene is flanked by loxP sites (Figure 3-1). Genotyping of the Mbp flox allel was 
performed by genomic polymerase chain reaction (PCR) using the following primers (5’- 
GGGTGATAGACTGGAAGGGTTG), (5’-GCTAACCTGGATTGAGCTTGC) and (5’- CAACGGGTTC-
TTCTGTTAGTCC). To inactivate Mbp expression in mature oligodendrocytes, exon 1 was 
excised in vivo by breeding to mice expressing an tamoxifen inducible CreErt2 under the 
control of the Plp promotor (Leone et al., 2003). Genotyping of the CreErt2 allele was 
performed using the following primers (5’-CAGGGTGTTATAAGCAATCCC), (5’-CCTGGA 
AAATGCTTCTGTCCG) including a primer pair for CNP as positive control (5’-GCCTTCAAAC-
TGTCCATCTC) and (5’-CCCAGCCCTTTTATTACCAC) 
 
2.1.2 Statistical analysis 
Statistical analysis was performed using Graphpad Prism 7. If not stated otherwise 
significance was calculated by two-tailed unpaired t-test. Levels of significance were 
displayed as p<0.05 (*), p<0.01 (**) and p<0.001 (***). Linear regressions and one-phase 
decay were calculated in Graphpad Prism 7 using the mean of animals per time point. 
 
2.1.3 Animal handling 
All experiments were performed in accordance with the German animal welfare law and the 
regulations of the State of Lower Saxony for animal experiments. The animals were kept 
with 2–5 animals per cage in 12h light dark-cycles and bred in the animal facility of the Max 
Planck Institute for Experimental Medicine. 
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2.1.4 Administration of Tamoxifen 
For knock-out induction 8-9W old mice were intraperitoneal injected with 1 mg Tamoxifen 
(100µl of 10mg/ml tamoxifen in corn oil) for 5 consecutive days, followed by a two-day 
break and 5 more days of injection. The resulting dosage is 10 mg per mouse over a 12 day 
period. The day after the last tamoxifen injection was considered 0 days post tamoxifen. 
Mice were analyzed 2 to 12 months after tamoxifen induction.  
 
2.1.5 PCR and qPCR primer  
Table 1: Primers used in this thesis 
Primer Fwd Primer [5'-3'] Rev Primer [5'-3'] 
Housekeeper 
RPS13 CGAAAGCACCTTGAGAGGAA TTCCAATTAGGTGGGAGCAC 
Ppia CACAAACGGTTCCCAGTTTT TTCCCAAAGACCACATGCTT 
RPLP0 GATGCCCAGGGAAGACAG ACAATGAAGCATTTTGGATAATCA 
 
Myelin Genes  
Mag AGGATGATGGGGAATACTGGT AAGGATTATGGGGGCAAACT 
Mog ACCTGCTTCTTCAGAGACCACT GGGGTTGACCCAATAGAAGG 
Cnp  CGCTGGGGCAGAAGAATAC AAGGCCTTGCCATACGATCT 
Mbp  GCCTCCGTAGCCAAATCC GCCTGTCCCTCAGCAGATT 
Plp1 CTCCAAAAACTACCAGGACTATGAG AGGGCCCCATAAAGGAAGA 
Car2 CAAGCACAACGGACCAGA ATGAGCAGAGGCTGTAGG 
Olig2 AGACCGAGCCAACACCAG AAGCTCTCGAATGATCCTTCTTT 
Pdgfr A AAGACCTGGGCAAGAGGAAC GAACCTGTCTCGATGGCACT 
Aif1 CCGAGGAGACGTTCAGCTAC TGTTTTTCTCCTCATACATCAGAATC 
S100b AACAACGAGCTCTCTCACTTCC CTCCATCACTTTGTCCACCA 
Aqp4 TGGAGGATTGGGAGTCACC TGAACACCAACTGGAAAGTGA 
Gfap TGCTCCTGCTTCGAGTCCTT TCAAGAGGAACATCGTGGTAAAGA 
Golli  CCTCAGAGGACAGTGATGTGTTT AGCCGAGGTCCCATTGTT 
 
Cholesterol genes  
Hmgcs1 AGCCAAAATCATTCAGGGTAAA GGACCGCTGCTATTCTGTCT 
Hmgcr TGATTGGAGTTGGCACCAT TGGCCAACACTGACATGC 
Fdft1 GGACCGCTGCTATTCTGTCT TCAATCAGACCAGTCGCAGC 
Dhc24 GGTCATGACGGACGACGTA AGGGCTTGTAGTAACTGCCAAT 
Cyp51 TTAGAACAGAAAGCAGTGTGTGG TGCATCTATCAAGTAAATTCAGATCC 
Srebp2  ACCTAGACCTCGCCAAAGGT GCACGGATAAGCAGGTTTGT 
Fdps  TGTAAGCCGCAAACATCTTG CCAATTTCTGGTTCCCATTC 
Apoe  GACCCTGGAGGCTAAGGACT AGAGCCTTCATCTTCGCAAT 
Apod ACGGAAACATCGAAGTGCTAA TGGCTTCACCCTTTACTTGG 
Ldlr GATGGCTATACCTACCCCTCAA TGCTCATGCCACATCGTC 
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2.1.6 Antibodies 
Table 2: Primary antibodies used in this thesis 
Antigen Host species Method Manufacturer 
Actin Monoclonal mouse WB (1:5000) Millipore  
APP Monoclonal mouse Paraffin IHC (1:750) Chemicon 
CD3 Monoclonal rat Paraffin IHC (1:150)  Abcam 
CNPase Monoclonal mouse Paraffin IHC (1:150) Sigma  
Clone 11-5B 
Iba1 Polyclonal goat Paraffin IHC (1:200)  Abcam 
ab5076 
Mac3 Monoclonal rat Paraffin IHC (1:500) BD Pharmingen 553322 
MBP Monoclonal rat Cryo IHC (1:400) Serotec MCA409S 




MBP Polyclonal rabbit IHC (1:4000)  
IEM: (1:250)  
Custom made (Kathrin 
Kusch) 
Nav 1.6  Polyclonal rabbit Cryo IHC (1:500) Alomone, ASC-009 
Caspr1 Monoclonal mouse Cryo IHC (1:500)  Neuromabs 
GFAP Monoclonal mouse Paraffin IHC (1:200)  Novocastra  
PLP 
(A431) 
Polyclonal rabbit Paraffin IHC (1:500) K.-A. Nave  
custom made A431  
Olig2 Monoclonal mouse Paraffin IHC (1:100) Gift from J. Alberta, 
custom made  
CAII Polyclonal rabbit Paraffin IHC (1:150)  Gift from Sahid G.  
custom made 
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Table 3: Secondary antibodies used in this thesis 
Antibody  Host species Method Manufacturer 
α-rabbit-HRP Goat IHC (1:10.000) Dianova 
 
α-mouse-HRP Goat IHC (1:10.000) Dianova 
 
α-mouse-Alexa  




IHC (1:1000) Dianova 
 
α-rabbit-Alexa  
488, 555,594 or 633 
Donkey IHC (1:1000) Dianova 
 
 




2.1.7 General buffers  
All buffers are prepared using ddH2O (deionized milli q-water) if not stated otherwise. 
Phosphate buffered saline (PBS)  
10X PBS stock solution (1L): 
1370 mM NaCL  [80.0 g] 
27 mM KCl   [2.0 g] 
80 mM Na2HPO4  [14.4 g] 
20 mM KH2PO4  [2.4 g]  
pH was adjusted to 7.1 using NaOH  
 
10x Tris-buffered saline (TBS) (1L) 
500 mM Tris/HCl, pH 7.5  [60.6 g] 
1.5 M NaCl    [87.6 g] 
 
Protein biochemistry buffer 
Modified RIPA Buffer  
1x TBS  
1 mM EDTA  
0.5% [w/v] Sodium deoxycholate 
1.0% [v/v] Triton X-100 
cOmplete™ Mini protease inhibitor (Roche Diagnostics GmbH) 
1 tablet per 10ml of RIPA buffer 
Protease inhibitor was added freshly to the RIPA buffer before use. 
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4X SDS-Sample buffer (10 ml) 
 
1.67 ml 1.5 M TRIS pH 6.8 
80 µl 0.5 M EDTA pH 8.0 
0.8 g SDS 
2 ml 0.2 % bromphenol blue 
400 µl β-mercaptoethanol 
4 ml glycerol 
Added up to 10 mL with ddH2O and stored at -20°C 
 
1x TBS with Tween-20 (TBS-T for WB) 
50 mM Tris/HCl, pH 7.5 
150 mM NaCl 
0.05% [v/v] Tween-20 
 
10x SDS running buffer (Laemmli buffer) (1L)  
250 mM Tris base [144 g] 
1.92 M Glycine  [30.28 g] 
1% [w/v] SDS   [10 g] 
 
Transfer buffer (1L)  
39 mM Tris base [29.25 g] 
48 mM Glycine  [58.148 g] 
10% [v/v] Methanol [100 ml] 
 
Milk blocking buffer for WB  
5% [w/v] non-fat dry milk powder (Hema) in 1x TBS-T  
 
Protein marker for SDS-Page  
PageRuler Plus Prestained Protein Ladder 10-250kDa  
(Thermo Scientific, Cheshire, UK) 
 
Buffers and reagents for electron microscopy 
Phosphate buffer (PB): 
0.1 M phosphate buffer (PB) was prepared as follows (1L): 
0.04 M NaH2 PO4 · H2O  [1.8 g] 
0.16 M Na2 HPO4 · 2H2O [15.5 g] 
Volume was added up to 1L with ddH2O 
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Karlsson and Schultz buffer 0.2M Stock solution: 
0.2 M Karlsson and Schultz  phosphate buffer was prepared as follows (1L):  
3.6 g NaH2 PO4 · H2O 
31 g  Na2 HPO4 · 2H2O 
10 g  NaCl 
Volume was added up to 1L with ddH2O 
 
Karlsson-Schultz fixative (Electron microscopy)  
4% [w/v] PFA 
2.5% [v/v] Glutaraldehyde 
In 0.1 M Karlsson and Schultz  phosphate buffer 
 
Immuno Karlsson-Schultz fixative (Cryo-Immuno Electron microscopy)  
4% [w/v] PFA 
0.25% [v/v] Glutaraldehyde 
In 0.1 M Karlsson and Schultz phosphate buffer 
 
Durcupan resin for FIB-SEM sample embedding 
Durcupan is a resin mixture used for samples embedded for FIB-SEM microscopy. In 
comparison to Epon it forms a harder and more inert resin. It is less prone to waving 
artifacts during cross-section milling and interacts less with the electron and the ion beam 
which results in less imaging artifacts in FIB-SEM milling and imaging. The Durcupan kit 
(Durcupan™ ACM, 44610, Sigma-Aldrich) consists of 4 components that are mixed on a 
magnetic stirrer.   
For 43.4 g Durcupan the following components were combined:  
Component A, M epoxy resin (Sigma-Aldrich, 44611)    22.8 g 
Component B, hardener 964 (Sigma-Aldrich, 44612)    20 g 
Component C, accelerator 960 (DY 060) (Sigma-Aldrich, 44613)  0.6 g 
Then 0.2 g component D was added as accelerator and crosslinker. The resulting mixture 
was slowly stirred for additional 20 mins before use.  
 
Epoxy Resin (Epon) for TEM sample embedding:  
For 47.1 g Epon the following components were mixed on a magnetic stirrer 
Glycidether 100 (Serva, 21045)      21.4 g 
2-Dodecenylsuccinic acid anhydride (DDSA) (Serva, 20755)  14.4 g 
Methylnadic anhydride(MNA) (Serva, 29452)    11.3 g 
Solution was slowly stirred for 15 mins. 
Then 0.84 mL 2,4,6-Tris(dimethyl-aminomethyl-)-phenol (DMP-30) (Serva) was added as 
accelerator. The resulting mixture was slowly stirred for additional 20 min before use.  
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Formvar solution 
612.5 mg Formvar (Plano, Wetzlar, Germany) is dissolved in 50 mL Chloroform and stirred 
for at least 30 minutes. The resulting solution is stored at RT protected from light. 
 
Richardson’s Methylene blue / Azure II blue 
Staining solution for lipid-rich regions in electron microscopy semi thin sections. Stock 
solutions were prepared as follows:  
1 % [w/v] Azure II (Merck, Darmstadt, Germany) in ddH2O (stock solution I) 
1 % [w/v] Methylene Blue (Merck, Darmstadt, Germany) in 1 % sodium borate (stock 
solution II) 
For a working solution equal volumes of the stock solutions were mixed in a syringe and 
filtered directly before use. Working solution was used for a maximum of 24h.  
 
Immunohistochemistry buffers:  
Paraformaldehyde 
4% [w/v] Paraformaldehyde 
In 0.1 M Phosphate buffer 
 
Citrate buffer (0.01 M, pH 6.0) (Immunohistochemistry) 
1.8 mM Citric acid (C6H8O7·H2O) 
8.2 mM Sodium citrate (C6H5O7Na3·2H2O) 
Citrate buffer was always prepared fresh  
 
Triple-Blocking solution for immunohistochemistry 
For 100 ml Stock solution (100%) the following blocking reagents were diluted  
in 100 mL 1X PBS: 
2 mL Fetal calf serum (FCS) 
2 g Bovine serum albumin (BSA) 
2 g fish skin gelatin 
 
10% BSA solution for immunocytochemistry 
For a 10% stock solution 10 g Bovine serum albumin (BSA) were diluted in 100 ml 1x PBS.  
 
Tris buffer (pH 7.6) 
50 mM Tris/HCl, pH 7.6 
0.9% [w/v] NaCl 




Eukitt Kindler for DAB labeled sections (Kindler, Freiburg, Germany) 
Aqua-Poly/Mount Polysciences for fluorescence labeled sections (Polysciences, 
Eppelheim, Germany) 
 
2.1.8 Manufacturer Kits  
Kits were used according to the manufacturer's guidelines  
Table 4: Commercial kits used in this thesis 
Kit Usage Manufacturer 




RNAeasy mini prep RNA isolation Quiagen, Hilden, Germany 
SuperScript III First-Str. 
Synth. 
Synthesis of cDNA from 
RNA 
Invitrogen 
DAB Zytomed Kit DAB IHC  Zytomed Systems GMBH  
 Click-iT EdU Alexa Fluor 
647 





Adult Brain Dissociation Kit 
mouse and rat with Anti-O4 
MicroBeads, and MS 
Columns 
Oligodendrocyte isolation 
from adult mouse brain  









Table 5: Software used in this thesis 
Software Application Manufacturer/Developer 
Adobe Photoshop 
CS5 
Image processing Adobe  
GraphPad Prism 7 Statistical analysis and data 
visualization 
www.graphpad.com 




ZEN Image processing and export Zeiss  
LasAF Image processing and export Leica 
Imaris 3D Data visualization Bitplane 
Microscopy Image 
Browser (MIB) 
EM data segmentation & analysis www.mib.helsinki.fi/ 
IMOD 4.9 EM data segmentation University of Colorado 
Boulder 
Excel 2013 Data analysis Microsoft 
Matlab 2016 Data analysis Mathworks 
Illustrator CS5 Figure design Adobe  
Rstudio 1.2 Data analysis RStudio Inc. 
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2.2 Methods 
2.2.1 Protein analysis  
2.2.1.1 Tissue lysis  
For whole brain Lysate, one hemisphere was homogenized in 4 ml modified RIPA buffer 
using a T-10 basic Ultra-Turrax (IKA, IKA®-Werke GmbH & CO. KG, Staufen Germany) for 
20-30 sec on speed setting 3-4. The homogenate was then centrifuged at 13.000 rpm for 10 
min at 4°C and the supernatant was transferred to a new tube. Protein concentration was 
determined in triplicates using the BCA protein assay kit (Pierce) according to the 
manufacturer's manual.  
 
2.2.1.2 Sodium Dodecyl Sulfate Polyacrylamide Gel 
Electrophoresis  
Proteins were separated according to their electrophoretic mobility and size by Sodium 
Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE). 1.5 mm thick Gels were 
self-casted using the BioRad system and contained a stacking and a 10% or 12% separation 
gel (Table 6). Samples for loading were prepared with equal protein amounts, mixed with 
SDS-sample buffer as well as 5% [v/v] mercaptoethanol and heated to 40°C for 10 minutes 
before loading. As a size reference 3 µl of the PageRuler Plus pre-stained protein ladder 
(Thermo Scientific, Cheshire, UK) were loaded in the outermost left lane. Electrophoresis 
was performed in a Biorad gel chamber filled with running buffer at 200 V until the dye 
front left the gel. Gels were subsequently used for Western blotting to detect proteins of 
interest by using antibodies.  
 
2.2.1.3 Western blot  
To transfer proteins from the SDS-PAGE gel onto a PVDF Membrane (Amersham) a BioRad 
WetBlot chamber was used. The PVDF membrane was activated in 100% [v/v] methanol 
for 1 min then washed two times in ddH20 before transfer. The gel and the respective 
membrane together with 4 filter papers on each side were transferred into a BioRad 
WetBlot chamber and transfer was carried out for 45min at 38V in 1x transfer buffer. To 
prevent nonspecific antibody binding, membranes were blocked in 5% non-fat dry milk in 
TBS-T for 1h at RT. After blocking a primary antibody against the protein of interest was 
diluted in 5% non-fat dry milk in 1x TBS with 0.1% Tween 20 (TBS-T) and incubated 
overnight at 4°C on a rotator. On the next day the membrane was washed three times for at 
least 15 min each with TBS-T followed by incubation with a horseradish peroxidase-
conjugated secondary antibody (dilution 1:10.000) in fresh 5% non-fat dry milk in TBS-T 
for 1 h at RT on a rotator. After incubation the membrane was washed three times for 15 
mins with TBS-T to remove unbound antibody. The membrane was developed using an 
advanced fluorescent and ECL Imager (Intas) and the Enhanced Chemiluminescence (ECL) 
Immunoblot detection kit Western Lightning (Perkin Elmer Life Sciences). The detected 
signals were saved as TIF files and analyzed using ImageJ (NIH) and compared to an 
appropriate loading control to determine relative protein amounts.  
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Table 6 Polyacrylamide gel preparation 
Reagent Stacking Gel  
[1 gel] 
Separation Gel (12%)  
[1 gel] 
ddH2O [1.025 ml] [3.9 ml] 
Acrylamid/ 
Bisacrylamid 29:1 
4% [w/v]  
[0.325 ml] 
12%[w/v]  
[3.725 ml]  
0.5M Tris HCL pH 6.8 125 mM Tris/HCl pH 6.8 
[0.625 ml]  
- 
1.5M Tris HCL pH 8.8 - 0.4 M Tris/HCl pH 8.8  
[3.25 ml] 
10% Sodium Dodecyl 
Sulfate 
- 0.1% [w/v] SDS 
[92 µl] 
10% Ammonium-persulfate 0.05% [w/v] APS 
[12.5 µl] 




0.1% [v/v] TEMED 
[2.5 µl] 
 
0.08% [v/v] TEMED 
[7.5 µl]  
 
2.2.2 Proteom analysis of optic nerves 
Whole optic nerves were homogenized in 250 µl ice cold modified RIPA buffer using teflon 
beads and a Precellys 24 tissue homogenizer (Bertin instruments, France). Homogenisation 
was carried out at a frequency of 5500 for 2x10 seconds. Samples were subsequently 
centrifuged at 13.000 rpm at 4°C and the supernatant was collected to reduce undissolved 
tissue and cellular nuclei. The protein concentration of the supernatant was determined in 
triplicates using the BCA protein assay kit (Pierce).  
For quality control 0.5 µg protein of each sample were loaded on a gel and SDS-PAGE with 
subsequent silver staining of the gel to detect protein band (Blum et al., 1987; Mortz et al., 
2001). Samples were then submitted to the proteome facility of the Max-Planck-Institute of 
Experimental Medicine headed by Dr. Olaf Jahn and processed as described previously 
(Ambrozkiewicz et al., 2018). Two digestion replicated of four optic nerves lysates per 
group and condition were measured by liquid chromatography coupled to electrospray 
mass spectrometry (LC-MS). Post identification analysis and peptide identification was 
performed by Dr. Olaf Jahn using ISOQuant (http://www.isoquant.net). Statistical 
evaluation of significant changes in protein abundance was performed by Lars Piepkorn 
using moderated t-statistics based on calculation of false discovery rates for multiple testing 
correction using the bioconductor packages “limma” and “q-value” in the Rstudio 
environment (Storey and Tibshirani, 2003; Ritchie et al., 2015). For heatmap visualization 
both digestion replicate measurements were averaged to receive 4 biological replicates per 
condition and time point then. Log2 fold changes between control and knock-out were 
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calculated and visualized in heatmaps where red represents increased and blue decreased 
protein abundance.  
Go-Term enrichment analysis was performed using the functional profiling feature (g:GO 
St) of g-profiler (https://biit.cs.ut.ee/gprofiler/). Proteins were sorted by abundance and 
separated into increased (>0) and decreased (<0) abundance relative to control (Log2 Fold-
change). Only proteins with a significantly changed abundance were used for enrichment 
(cut off threshold q-value <0.05). Protein Database accession IDs were used as identifiers 
and compared to the mus musculus background. The gSCS threshold was used to describe 
the significance of enrichment together with an additional used defined 0.05 threshold. The 
top 20 enriched pathways of upregulated gene obtained from the KEGG database were 
visualized including the adjusted enrichment p-values (Kanehisa and Goto, 2000; Kanehisa 
et al., 2017, 2019).  
 
2.2.3 Lipidome analysis  
For lipid analysis, mice 8W pti and 16W pti were sacrifice by cervical dislocation followed 
by extraction of optic nerve and brain. Complete optic nerves were directly transferred in 
0.5 ml Precellys tubes filled with Teflon beads and placed on dry ice. Brains were sectioned 
in 300 µm slices in ice cold PBS using a vibratome (VT1200S, Leica, Vienna, Austria) and 
four 1.5 mm diameter biopsy punches (Harries Unicore 1.5mm, GE Healthcare, United 
Kingdom) of caudal corpus callosum from 3 consecutive sections were transferred to 0.5 ml 
Precellys tubes and immediately placed on dry ice. Mass spectrometry measurements were 
performed by Prof. Britta Brügger (Biochemistry center at the university of Heidelberg 
(BZH) as described previously (Özbalci et al., 2013) using a QTRAP 6500 LC-MS/MS System. 
A lipidome profile was obtained for optic nerve and corpus callosum of 4 animals per 
condition at 8W and 16W pti.  
 
2.2.4 Isolation of oligodendrocytes by magnetic cell isolation 
(MACS) 
Isolation of oligodendrocytes from mice 16 W pti was performed in collaboration with Lena 
Spieth, Stefan Berghoff and Tim Düking (Group of Gesine Saher, Max-Planck-Institut of 
Experimental Medicine). Oligodendrocytes were isolated by Lena Spieth according to the 
manufacturers protocol (Adult Brain Dissociation protocol, Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany). Corpus callosum was dissected using a brain matrix, manually reduced 
to small pieces using a scalpel and transferred to round bottom tubes with appropriate 
amount of dissociation enzymes mix 1 on ice. After dissection enzyme mix 2 was added and 
samples were dissociated at 37°C for 30 min. Cells were then washed with PBS and passed 
through a 70°µm strainer and centrifuged (Heraeus Biofuge Pico table centrifuge) at 300 g 
for 10 min at 4°C. The pellet was resuspended in PBS + Debris Removal Solution and 
centrifuged at 3000 g for 10 min at 4°C. The upper two phases were removed washed with 
PBS and centrifuged at 1200 g for 10 min. The pellet was then incubated in 1x Red blood 
cell removal solution and after 10 min washed with PBS and centrifuged at 3000 g for 
10 min at 4°C. The cell pellet was resuspended in appropriate amounts according to the 
antibody Microbead kit protocol. To label the oligodendrocyte fraction the pellet was 
incubated with 2.5 µl anti-O4 Microbeads in 97.5 µl PBS for 15 min. For removal of unbound 
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Microbeads 1 ml PBS was added followed by centrifuged at 300 g for 10 min at 4°C. Cells 
were then resuspened in 0.5 ml PBS. MS Columns used for magnetic isolation were attached 
to the Octomacs magnet, equilibrated with 0.5 ml PBs and loaded with microbead cell 
suspension. The columns were washed three times with PBS and detached from the magnet. 
Purified oligodendrocytes were then eluted in 0.5 ml of RLT buffer for mRNA isolation and 
stored at -80°C. Due to low RNA yield, cDNA amplification by single primer isothermal 
amplification (SPIA) from NuGEN was performed according to the manufacturers protocol.  
 
2.2.5 mRNA analysis  
2.2.5.1 RNA-Isolation and cDNA synthesis  
Tissue was homogenized in ice cold 4 ml QIAzol Lysis Reagent (Qiagen, Hilden, Germany) 
using a T-10 basic Ultra-Turrax (IKA, IKA®-Werke GmbH & CO. KG, Staufen Germany) for 
20-30 sec on speed setting 3-4 according the manufacturers guidelines. The Ultra-Turrax 
was cleaned with 70% EtOH and H2O between every homogenization. Corpus callosum 
samples were homogenized in 1 ml QIAzol using teflon beads and a Precellys 24 tissue 
homogenizer. Homogenisation was carried out at a frequency of 5500 for 2x 10 seconds. 
Samples homogenized in QIAzol are stable at RT. Of each sample 1 ml was collected, mixed 
with 200 µl chloroform, briefly vortexed and incubated for 2-3 min at RT. Samples were 
then centrifuged at 13.000 rpm for 15 min (Heraeus Biofuge Pico table centrifuge). The 
transparent upper aqueous phase of approximately 700 µl was transferred to a new tube 
and an equal volume of fresh 70% EtOH was added. The volume was well mixed by pipetting 
and transferred to a RNeasy Mini column (RNeasy Mini Kit, Quiagen, Hilden, Germany). RNA 
was then isolated according to the manufactures protocol and resuspended in 30-100 µl 
Rnase free water. Quality and amount the isolated RNA were determined by using the 
Agilent RNA 6000 Nano KIT and the Agilent 2100 Bioanalyzer following the company’s 
guidelines. Only RNA with an integrity index of at least 8.5 was used for further experiments.  
 
2.2.5.2 cDNA synthesis 
To quantify the amount of RNA transcripts via qRT-PCR the isolated RNA was converted 
into single stranded cDNA. First-strand cDNA synthesis was carried out via a reverse 
transcription reaction catalyzed by the RNA dependent DNA polymerase SuperScript III 
(Invitrogen). In a first step, primer and random nonamers are added to the RNA. Mix 1: 
800 ng RNA in 8 μl Rnase free water, 2 μl dT mix Primer (0.6 pmol/μl) and 2 μl N9 (random 
nonamers 120 pmol/μl). This first mix was then incubated for 10 min at 70°C to denature 
RNA and primers followed by a 1 min incubation on ice.  
Then, 4 μl 5x first strand buffer, 1 μl dNTP (10 mM), 2 μl DDT (100 mM) and 1 μl SuperScript 
III reverse transcriptase (200 U/μl) were added. The complete mixture was incubated in a 
thermocycler with the following protocol: 25°C 10 min, 50°C 45 min, 55°C 45 min. The 
synthesized cDNA was then diluted to 5 ng per µl and stored at -20°C. 
 
2.2.5.3 Quantitative real time PCR (qRT-PCR) 
qRT-PCR was used to determine the relative amount of the transcript of interest for each 
sample. Analysis was performed using SYBR Green Master Mix according to the 
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manufacturer’s instructions (Applied Biosystems, Darmstadt, Germany). qRT-PCR was 
performed with the following mixture per well: 5 µl 2x SYBR Green Master Mix, 10 ng cDNA 
in 2 µl rnase free water, 0.4 µl forward (10 pmol/µl) and 0.4 µl reverse (10 pmol/µl) primer 
and 2.8 µl rnase free water. 
Primers were designed using the Universal Probe Library form Roche Applied systems 
(https://www.roche-applied-science.com) and validated using NIH PrimerBlast 
(www.ncbi.nlm.nih.gov/tools/primer-blast/). Each reaction was performed in triplicates 
using the following qRT-PCR program: Initial 95°C for 10 sec to activate the enzyme 
followed by 45 cycles of 95°C for 15 sec and 60°C for 1 min on a LightCycler® 480 
Instrument II (Roche). Relative mRNA abundance was quantified using the 
LightCycler® 480 Instrument II software and expressed as relative fold change of control. 
mRNA Abundance was, if not stated otherwise, normalized to RPS13 and Ppia.  
 
2.2.6 Histological analysis  
2.2.6.1 Tissue collection 
Animals designated for histological analysis were sedated by i.p. injection of Avertin (0.2 ml 
per 10 g of body weight) and after confirmed sedation prepared for transcardial perfusion. 
The lower abdomen was opened with surgical scissors, the diaphragm was removed and a 
butterfly needle (27G, Venofix) was inserted into the left ventricle of the heart while the 
right atrium was opened to allow blood to leave the circulatory system. A piece of tail was 
removed for later re-genotyping. Then, a peristaltic pump was used to perfuse the 
circulatory system at a speed of 1 mL/min for 5 min with HBSS at RT (Invitrogen, Karlsruhe, 
Germany) to flush out blood followed by 10 to 15 min of perfusion with 4% PFA in 0.1 M PB 
to fix the tissue.  
 
2.2.6.2 Immunohistochemistry of cryostat sections  
For cryostat sectioning mice were perfused with 4% PFA in 0.1M PB and the extracted 
organs were kept in fixative for post-fixation for 10 min (optic nerve) or 12 h (brain and 
spinal cord). After fixation, tissue was incubated for cryoprotection for 2-3 days in 30% 
sucrose at 4°C. Tissue that was successfully infused with sucrose sank to the bottom of the 
used container. The tissue was then covered in Tissue-Tek® O.C.T. Compound (Sakura® 
Finetek) for stabilization and was frozen and stored at -20°C to -80°C. A cryostat (Leica, 
Vienna, Austria) was then used to cut sections of stabilized tissue. Optic nerve sections of 8-
9 µm were prepared. The sections were collected on glass slides, dried at 37°C for 1 h and 
then stored at 4°C or -20°C. For immunofluorescent labeling, the sections were washed 
three times 10 min in PBS followed by permeabilization for one hour in 0.4% Triton-100 in 
PBS. Sections were blocked for 1 h in 1:2 triple-blocking solution for immunohistochemistry 
diluted in 1x PBS. The primary antibody was then diluted in the blocking solution and 
incubated overnight at 4°C. On the next day, slides were washed thrice with 1x PBS for 
15 min each and incubated with the fluorescently labeled secondary antibody for 1 h at RT. 
After the incubation the slides were once again washed thrice with 1x PBS for 15 min each, 
incubated with DAPI for 20 min and washed again before being mounted using Aqua-
Poly/Mount (Polysciences). Sections where stored at 4°C until imaging.  
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2.2.6.3 Confocal and epifluorescence imaging  
Fluorescent slides were imaged on an Axio-Observer epifluorescence microscope (Zeiss) 
using the software ZEN. For imaging a UV-lamp and filter cubes specific for the appropriate 
fluorophore were used.  
Fluorophore Filter Cube  
Alexa 488 GFP 
Alexa 555 dsRed 
Alexa 633 Cy5  
Confocal images were acquired on a SP5 Leica confocal microscope. Fluorescent signals 
were imaged sequentially to avoid cross bleeding using an HCX PL APO lambda blue 
63.0x1.20 WATER UV objective. The following laser lines were used for the specific 
fluorophores:  
Argon Laser at 488nm was used to excite Alexa 488   
Argon Laser at 514nm was used to excite Alexa 555   
A HeliumNeon (HeNe) laser at 633nm was used to excite Alexa 633 and Alexa 647.  
The confocal software LasAF was used for image acquisition and resulting images were 
saved as .lif and quantified using FIJI.  
 
2.2.6.4 Paraffin embedding of tissue and Immunohistochemistry 
For paraffin embedding mice were perfused with 4% PFA in 0.1 M PB and the extracted 
organs were kept in fixative for post-fixation of 12 h. After fixation, tissue was embedded in 
paraffin (Paraplast, Leica, Wetzlar, Germany) using an automated embedding system (HMP 
110, MICROM).  
Protocol for paraffin embedding:   
50% [v/v]  Ethanol  1x1 h  
70% [v/v]  Ethanol  2x2 h  
96% [v/v]  Ethanol  2x2 h  
100% [v/v] Ethanol  2x2 h  
100%   Isopropanol 1x1 h  
100%  Xylol   2x 2 h  
100%  Paraffin  2x 2 h 
After infusion with paraffin the samples were positioned in metal forms filled with paraffin 
and casted into paraffin blocks. The blocks were transferred to a cooling plate to solidify 
and afterwards stored at RT. Blocks were then cut in 5 µm thick sections using a manual 
microtome (HM 400, MICROM). Sections were transferred to a 37°C water bath to unfold 
and collected on glass slides. At least two sections were collected per slide as replicates for 
later analysis. Slides with sections were dried overnight at 37°C and stored at room 
temperature.  
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2.2.6.5 Immunohistochemistry of Paraffin embedded sections  
Before labeling, paraffin sections were deparaffinized by the following protocol  
Melting of surrounding paraffin at 60°C  10 min 
Xylol  100%      10 min 
Xylol  100%      10 min 
Xylol 50% + Isopropanol 50%   10 min 
Ethanol 100% [v/v]     5 min 
Ethanol 90% [v/v]     5 min 
Ethanol 70% [v/v]     5 min 
Ethanol 50% [v/v]     5 min 
ddH2O      5 min 
 
Deparaffinized 5 µm section were then used to label the histopathological markers GFAP, 
Mac3, CD3 and APP using chromogenic detection, Carboanhydrase II, Olig2 and PDGFRA 
were labeled using antibodies conjugated to fluorophores. 
For fluorescent or DAB labeling deparaffinized section were transferred into glass cuvettes 
and incubated in citrate buffer for 5 min. Section were then transferred into a plastic cuvette 
filled with hot citrate buffer and boiled  for 10 min (600 W, microwave) to facilitates heat 
induced antigen retrieval as well as permeabilization. After boiling the section were left to 
cool in citrate buffer for 20 min. Then, sections were rinsed with Tris buffer containing 2% 
non-fat dry[w/v] milk powder for 5 min and fixed into Shandon coverplates (Thermo 
Scientific, Cheshire, UK).  
Sections used for DAB labeling were treated by applying 100 µl 3% [v/v] hydrogen peroxide 
for 5 min endogenous peroxidase activity in the section was inhibited. This is necessary to 
prevent endogenous peroxidases from converting the later used DAB substrate into 
nonspecific background signal. The sections were then rinsed three times with Tris buffer 
containing 2% [w/v] non-fat dry milk powder. Slides were then incubated in the blocking 
solution (20% [v/v] goat serum in PBS/BSA [1%]) for 10 to 30 min at RT. The used primary 
antibody was diluted in PBS/BSA [1%], applied to the slides fixed in coverplates and 
incubated overnight at 4°C. On the next day, the sections were rinsed with Tris buffer 
containing 2% [w/v] non-fat dry milk powder.  
Sections used for fluorescent labeling were incubated with secondary antibody conjugated 
to a fluorophore (1:1000) and DAPI (1:10.000 of a 1 mg/ml Dapi stock solution) in PBS/BSA 
[1%] for 1 h at RT. After incubation section were rinsed 3x 10 min with Tris buffer 
containing 2% [w/v] non-fat dry milk powder. For embedding sections were mounted in 
Aqua-Poly/Mount (Polysciences) and stored at 4°C.  
Sections used for DAB labeling were instead incubation with 100 µl of biotinylated bridging 
antibody from the LSAB2 kit (Dako, Hamburg, Germany) for 10 min at RT and rinsed with 
tris buffer containing 2% [w/v] non-fat dry milk powder. A horseradish peroxidase (HRP) 
coupled secondary antibody was applied and incubated for 10 min followed by a rinsing 
step with Tris buffer containing 2% [w/v] non-fat dry milk powder. The HRP substrate 3,3'-
Diaminobenzidine (DAB) from the the DAB Zytomed Kit (Zytomed Systems GmbH, Berlin, 
Germany) was applied and incubated for 10 min. Brown DAB precipitate developed in the 
section at sites where the antigen of interest was detected by the set of primary followed by 
secondary antibodies with HRP. Sections were washed twice with ddH20 for 5 min and 
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incubated for 5 min in 0.1% [w/v] Haematoxylin to label nuclei in blue. After two rinsing 
steps with ddH20, sections were briefly incubated in HCL-Alcohol (0.09% [v/v] HCL, 70% 
[v/v] Ethanol), rinsed in ddH20 and incubated for 5 min in Scott’s solution (0.2% [w/v] 
Potassiumhydrogencarbonate 2% [w/v] Magnesium sulphate). After a rinsed in ddH20, 
slides were incubated in 0.1% [w/v] Eosin (0.1% [v/v] Eosin in ddH20) for 3-5 min as 
counterstaining and rinsed in ddH20. For embedding and longtime storage tissue was 
dehydrated via an increasing ethanol series with 5 min incubation for the following steps 
(50% [w/v], 70% [w/v], 90% [w/v], and 100% [w/v]), incubation in Xylol/Isopropanol 
(1:1) followed by two times Xylol and mounted in Eukitt (EUKITT, o-kindler, Germany)  
 
2.2.7 Myelin purification 
This purification protocol is based on a method developed by Norton and Poduslo to isolate 
a compact myelin fraction by ultracentrifugation and sucrose gradients (Norton and 
Poduslo, 1973; Larocca and Norton, 2007) and is performed as previously described (Jahn 
et al., 2013; Erwig et al., 2019). Buffers, solutions and glassware were cooled to 4°C and all 
preparation steps were performed on ice. Myelin purification was performed on a maximum 
of 6 samples per preparation as limited by the number of buckets fitting into the 
ultracentrifuge.  
Using a Kinematica AG Polytron PT 3000 homogenizer, half a mouse brain was completely 
homogenized in 0,32 M sucrose supplemented with protease inhibitors (Roche Complete, 
Roche Diagnostics GmbH, Mannheim, Germany). Brain homogenates were then stored on 
ice until all 6 samples were homogenized. 300 µl of homogenate per brain were collected 
and stored at -80°C. New Ultra-Clear centrifuge tubes (Beckman No. 344060) were filled 
with 0,85 M sucrose. The brain homogenate was then carefully layered on top of the 0,85 M 
sucrose using a 10 ml pipette. For all following centrifugation steps the tubes were carefully 
adjusted for tara down to 0.01 g to avoid any imbalances. The homogenate filled tubes were 
then centrifuged for 30 min at 70000 g in a swing out rotor (SW40Ti Beckman rotor, 
24.400 rpm) in a Sorvall WX ultracentrifuge (Thermo Scientific, Cheshire, UK). After 
centrifugation the tubes were kept on ice and the white interface between the sucrose layers 
was collected by using a fine glass pasteur glass pipette and transferred to a new clean tube. 
Water was added to perform a first osmotic shock and the tubes were centrifuge for 15 min 
at 70.000 g. The resulting pellet was resuspended in water for 15 min (second osmotic 
shock) and centrifuged at 12000 g for 15 min (SW40Ti Beckman rotor, 9700rpm). The 
resulting pellet was then resuspended in 0,32 M sucrose. A new tube was filled with 0,85 M 
sucrose and the resuspended pellet was layered on top as before. Tubes were then 
centrifuged for 30 min at 70000 g in a swing out rotor (SW40Ti Beckman rotor, 
24.400 rpm). The resulting interphase was collected by using a fine glass pasteur glass 
pipette and transferred to a new clean tube. Water was added to the tube to wash the 
interphase followed by 15 min centrifugation at 70000 g (SW40Ti Beckman rotor, 
24.400 rpm). The resulting pellet contained a purified myelin fraction and was resuspended 
in 200 µl 1x TBS containing protease inhibitors and stored at -80°C (Roche Complete, Roche 
Diagnostics GmbH, Mannheim, Germany). 
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2.2.8 EdU labeling of proliferating cells in vivo  
To assess the proliferation of oligodendrocytes after induction of MBP knock-out animals 
were supplied with 5-ethynyl-2′-deoxyuridine (EdU) in drinking water. This thymidine 
analog incorporates into the DNA of dividing cells and allows the visualization of cell that 
divided during the feeding period. Male mice 32 and 40 weeks after tamoxifen injection 
were supplied with 0.2 mg/ml EdU in drinking water for 3 weeks. Water was prepared 
freshly every 2-3 days and animals consumed between 6 and 9 ml per mouse per day. 
Animals were transcardially perfused for histological analysis 3 weeks after EdU 
administration was finished to allow for differentiation of the labeled cells. Paraffin sections 
of coronal brain slices were prepared as described previously. Brain slices were 
deparaffinized and labeled for EdU using the Click-iT EdU Alexa Fluor 633 (Thermo 
Scientific, Cheshire, UK) according to the manufacturer's protocol. After EdU labeling the 
paraffin sections were labeled for CAII, Olig2 or PDGFRA as described previously (2.2.6.4) .  
 
2.2.9 Electron microscopy  
2.2.9.1 Conventional Fixation  
Animals designated for ultrastructural analysis were transcardially perfused for 5 min with 
HBSS followed by 10-15 min perfusion with Karlsson-Schultz fixative (see 2.2.6.1). The 
perfused tissue was post-fixed in Karlsson-Schultz fixative for at least 12h.  
In case only parts of the animal were collected for ultrastructural analysis, animals were 
sacrificed by cervical dislocation. Optic nerves were removed from the brain and directly 
immersed in Karlsson-Schultz fixative. Larger tissues like brain or spinal cord were 
collected, immersed in cold PBS and cut on a vibratome (VT1200S, Leica, Vienna, Austria). 
Brain was cut into 200 µm thick sagittal sections, spinal cord was coronally cut into 100 µm 
sections and immersion fixed in Karlsson-Schultz fixative for at least 12 h before 
embedding.  
 
2.2.9.2 Conventional embedding  
Karlsson-Schultz fixed samples were transferred to 0.1 M PB and the region of interest was 
isolated by using a biopsy punch (Harries Unicore 1.5 mm, GE Healthcare, United Kingdom). 
Punches or whole optic nerves were then wrapped in tea filter paper and sorted into 
segmented plastic baskets (Science Services, Munich, Germany), transferred into a Lynx 
Tissue Processor II (Science Services, Munich, Germany) and prepared for embedding using 
the following protocol: 
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Table 7 Conventional embedding for EM 
Reagent Time Temperature 
0.1M PB  3x10 
min 
4°C 
2 % OsO4 4 h  4°C 
0.1M PB  3x10 
min 
4°C 
30 % acetone 20 min RT 
50 % acetone 20 min RT 
70 % acetone 20 min RT 
90 % acetone 20 min RT 
100 % acetone 10 min RT 
100 % acetone 10 min RT 
100 % acetone 10 min RT 
100 % acetone 10 min RT 
acetone /Epon 2:1 2 h RT 
acetone /Epon 1:1 2 h RT 
acetone /Epon 1:2 4 h RT 
Epon 100% 4 h RT 
 
After dehydration and Epon infiltration optic nerves were transferred into embedding 
molds and covered with Epon resin. Punches from spinal cord and brain were placed flat on 
parafilm-covered glass slides and covered with Epon-filled gelatin capsules. All blocks were 
polymerized for 24 h at 60°C. 
 
2.2.9.3 Modified ROTO embedding  
Samples used for FIB-SEM imaging fixed with Karlsson-Schultz fixative were embedded 
using a high heavy metal protocol to enhance contrast and signal of membrane in the SEM. 
The reduced Osmium/TCH/Osmium protocol (ROTO) is based on Mikula and colleagues  
(Mikula et al., 2012) and was modified for improved myelin preservation and visualization 
in the FIB-SEM. Optic nerves were wrapped in tea filter paper and transferred into 
segmented plastic baskets (Science Services, Munich, Germany) Baskets were mounted on 




Reduced OsO4:  50% PB (0,2 M) + 45% OsO4 (4%) + 5% K3[Fe(CN)6] (10%) 
TCH:   0.1 g thiocarbohydrazide in 10 ml ddH2O 
OsO4:   50% PB (0,2 M) + 50% OsO4 (4%) 
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Table 8 Modified ROTO embedding 
Reagent Time Temperature 
0.1M PB  3x15 min 4°C 
OsO4 2% + KFECN 3 h 4°C 
ddH2O  3x15 min 4°C 
thiocarbohydrazide  1 h RT 
ddH2O  15 min RT 
OsO4 2% 1.5 h RT 
ddH2O  15 min RT 
2% uranylacetate over night 4°C 
- 
  
ddH2O  3x15 min RT 
30% acetone 15 min RT 
50% acetone 15 min RT 
75% acetone 15 min RT 
90% acetone 15 min RT 
100% acetone 45 min RT 
25% Durcupan in acetone 2 h RT 
50% Durcupan in acetone 2 h RT 
75% Durcupan in acetone 2 h RT 
100% Durcupan in acetone over night RT 




After Durcupan infiltration optic nerves were transferred into embedding molds filled with 
Durcupan and polymerized for 48 h at 60°C. 
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2.2.9.4 High pressure freezing and Automated freeze substitution 
High pressure freezing (HPF) is a state-of-the-art method of electron microscopy sample 
preparation that uses high pressure and rapid cooling with liquid nitrogen. It allows the 
quasi instantaneous cryo immobilization of tissue which results in structural preservation 
that is very close to the natural state (Vanhecke et al., 2008) During freezing the water 
within the tissue turns into amorphous ice without forming crystals that would damage the 
ultrastructure. During freeze substitution the ice in the sample is exchanged with acetone 
while fixing and contrasting the samples at low temperatures. This exchange at very low 
temperatures avoids dehydration and degradation artefacts often found in conventionally 
fixed tissue (Korogod et al., 2015) and yields excellent structural preservation. 
Successful High pressure freezing requires specism to be 200 µm or thinner to allow high 
quality cryo fixation. To achieve this, mice are sacrificed by cervical dislocation and the 
tissue of interest is immediately collected. To obtain high pressure freezing samples of the 
optic nerve it was quickly separated from the brain and immersed in ice-cold PBS as 
preparation for freezing. One arm of the optic nerve was cut into two 1.5 mm pieces for HPF. 
For corpus callosum samples one brain hemisphere was immersed in ice cold PBS and 
200 µm thick sagittal sections were obtained using a vibratome (VT1200S, Leica, Vienna, 
Austria). A biopsy punch (Harries Unicore 1.5 mm, GE Healthcare, United Kingdom) was 
used to extract a region of interest in the rostral or caudal corpus callosum of a medial 
vibratome slice.  
The respective sample was then transferred into a drop of 20% [w/v] PVP (20% 
Polyvinylpyrrolidon, Sigma) in PBS and carefully positioned in the HPF A carrier (specimen 
carrier, Type A and B, (Leica, Vienna, Austria)) avoiding artefacts like tearing. Excessive 
liquid is removed with a Whatmann filter paper. A carrier B was wetted with hexadecene 
and added. The resulting carrier sandwich was inserted into a plastic carrier and frozen 
using a HPM100 high pressure freezer (Leica, Vienna, Austria). The frozen samples were 
transferred to cryovials and stored in liquid nitrogen until automated freeze substitution 
(AFS). AFS was carried out as described using a Leica AFS 2. Samples were substituted using 
0.1% Tannic acid (Sigma Aldrich, Munich, Germany) in glass-distilled acetone (Science 
Services, Munich, Germany) and 2% osmium tetroxide (Sciences Services, 
Munich,Germany) (Möbius et al., 2010). 
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Table 9 Freeze substitution 
Reagent Time Temperature 
0.1% tannic acid in glass distilled acetone   24 h -90°C 
-90°C cold acetone (pre cooled in the AFS) 4 x 30 min -90°C 
2% OsO4 + 0.1% uranylacetate in acetone 7 h -90°C 
2% OsO4 + 0.1% uranylacetate in acetone 14 h warm up to -20°C  
in 5°C steps per h  
2% OsO4 + 0.1% uranylacetate in acetone 16 h -20°C 
2% OsO4 + 0.1% uranylacetate in acetone 2.4 h warm up to 4°C in  
10°C per h increment 
2% OsO4 + 0.1% uranylacetate in acetone 1 h  4°C 
Temperature matched glass distilled acetone 4x 30 min 4°C 
Temperature matched glass distilled acetone 1 h RT 
33% Epon in Acetone  2h RT 
50% Epon in Acetone  2h RT 
66% Epon in Acetone  2h RT 
90% Epon in Acetone  over night RT 
100% Epon  4h RT 
 
Following freeze substitution, the samples were removed from the sample carrier and 
transferred into embedding molds filled with Epon. Blocks were polymerized at 60°C for 
24 h.  
 
2.2.9.5 Fixation for immunoelectron microscopy (IEM) 
For immunoelectron microscopy (IEM) optic nerves were collected fresh and immersion 
fixed in Immuno-Karlsson-Schultz fixative overnight at 4°C and then stored in 1% [w/v] Pfa 
in 0.1M PB. 
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2.2.9.6 Tokuyashu sectioning and Immuno electron microscopy 
To visualize the ultrastructural localization of myelin proteins in the optic nerve cyro-
immuno electron microscopy on cryosections was performed as described previously 
(Werner et al., 2007; Möbius et al., 2010). Optic nerves were dissected and immersion fixed 
in immuno Karlsson-Schultz fixative overnight. Nerves were then cut in 1-2 mm short 
pieces, stained with toluidine blue, embedded in 10% gelatin as cubes and infiltrated 
overnight in 2.3 M sucrose in 0.1 M PB as cryoprotectant. The cubes were then mounted 
onto aluminum pins for cryo-sectioning, and frozen in liquid nitrogen. Ultrathin 50-80 nm 
Tokuyashu sections were cut with a DiATOME Diamond knife, cryo-immuno 2,0 mm 
(Diatome, Biel, Switzerland) using a Leica UC6 ultramicrotome with a FC6 cryochamber 
(Leica, Vienna, Austria).The sections were picked up in a 1 to 1 mixture of 2% 
methylcellulose and 2.3 M sucrose using a perfect loop (Diatome, Biel, Switzerland), 
transferred to carbon coated EM grids and stored at 4°C (Liou et al., 1996). For labeling, EM 
grids with sections were placed on PBS droplets and washed 3 x 2 min to remove the pick-
up-solution followed by 3 x 2 min washing steps with 0,1% glycine (Serva, Heidelberg, 
Germany) in PBS to quench aldehydes. Sections were then blocked for 3 min using 1% BSA 
in PBS and incubated with rabbit anti PLP (1:250 A431, custom made K.A.-Nave) or rabbit 
anti MBP (1:250, custom made (Kathrin Kusch), 1:250) in 1% BSA in PBS for 1 h. Sections 
were then washed in 0.1% BSA in PBS for 5 x 2 min followed by 30 min incubation with 
protein A-gold 1:50 (10 nm, (CMC, Utrecht) in 1% BSA in PBS. Sections were washed 5 x 
2 min with PBS followed by fixation of antibodies by 5 min 1% glutaraldehyde in PBS 
incubation.  
To reduce phosphate that could interfere with contrasting the sections were washed 10 x 
1 min in ddH2O and contrasted for 5 min in neutral uranyl acetate (2% in 1.5 m oxalic acid, 
pH adjusted to 7.0 with ammonium hydroxide). For embedding grids were transferred to 
1.8% methylcellulose containing 0.4% uranyl acetate on ice, incubated for 5 min, and picked 
up with a custom-made wire loop. Excess liquid was removed from the loop via Whatman 
filter paper and grids were air-dried.  
 
2.2.9.7 Ultrathin sectioning and Electron microscopy  
Epon or Durcupan embedded tissues were cut using a Leica UC7 ultramicrotome (Leica, 
Vienna, Austria) and a DiATOME diamond knife, ultra 35° 3,0 mm. (Diatome, Biel, 
Switzerland). Blocks were trimmed and 500 nm semi-thin sections were cut and 
transferred to glass slides. Semi-thin sections were then stained with methylene 
blue / Azure II blue for 30-45 sec to visualize lipid rich areas in the tissue to confirm the 
region of interest. Ultrathin sections of 50-60 nm were cut and transferred to copper mesh 
grids (Science Services, Munich, Germany) and air dried. The section were contrasted with 
Uranyless for 30 min (Electron Microscopy Sciences, Hatfield, U.S.A), washed 5 times with 
ddH20 and dried for 30 min. Sections were analyzed with a LEO EM912 Omega (Zeiss, 
Oberkochen, Germany), and digital electron micrographs were obtained with a wide-angle 
dual speed 2K-CCD-camera (TRS, Moorenweis, Germany) using the microscope software 
ImageSP (Sys-Prog, Minsk, Belarus) or iTem (Olympus,Tokyo, Japan). 
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2.2.9.8 Focussed ion beam scanning electron microscopy  
Focussed ion beam scanning electron microscopy (FIB-SEM) allows to visualize the 
ultrastructure of tissue not only as 2D sections but as 3D volumes. This enables the analysis 
of ultrastructural morphology of three-dimensional myelin structures like outfoldings or 
myelin channels. 3D analysis of this kind was previously possible by serial sectioning but 
very labor intensive or limited to very small volumes by using tomography. Answering these 
questions is now becoming more feasible and distinctly faster using FIB-SEM. 
To analyze the loss of myelin basic protein in 3D, optic nerves were prepared for electron 
microscopy by ROTO embedding (see 2.2.9.3) or HPF (see 2.2.9.4) and prepared for volume 
acquisition in the FIB-SEM. After infiltration in Durcupan optic nerves were minimal 
embedded by removing as much resin as possible. To achieve this, nerves were cut in 1-2 
mm long pieces and moved on a piece of aclar (ACLAR® Fluoropolymer, Science Services, 
Munich) until no visible Durcupan layer was left on the nerve (Schieber et al., 2017). This 
technique allows easy targeting and faster sample preparation of a region of interest (ROI) 
inside the FIB-SEM. The minimal embedded nerves were polymerized on aclar for 72 h at 
60°C and mounted on SEM stubs (12.7x3.1 mm Science Services, Munich, Germany) using 
conductive silver epoxy (Electron Microscopy Sciences, Hatfield, U.S.A), covered in silver 
paint (Plano, Wetzlar, Germany) and polymerized overnight at 60°C. Samples were then 
sputter coated (Leica Ace 600, Vienna, Austria) with 5-8 nm platinum to limit charging and 
destruction of the surface during milling and imaging. The samples were then transferred 
into a Zeiss Crossbeam 540 (Zeiss, Oberkochen, Germany) and stored at vacuum overnight. 
On the next day the sample was positioned at an angle 54° to allow orthogonal cutting. Using 
the software SmartFIB (Zeiss, Oberkochen, Germany) a platinum pad of about 500 nm was 
deposited on the area of interest using the FIB at 3 nA current. This is done to protect the 
surface of the sample and support even milling. A coarse trench was milled to access the 
region of interest using a 15 nA FIB milling beam followed by polishing of the block face 
with 7 nA. For imaging, the FIB was used at 1.5 nA with a destined milling depth of 30 µm. 
FIB milling and SEM imaging were performed simultaneously (Narayan et al., 2014) and 
images were acquired at 1.5 kV using the software Atlas 5 (Atlas 3D package, Fibics, Ottawa, 
Canada). For the acquisition an energy selective backscattered (EsB) detector was used at a 
grid voltage of 1100 V, analytical mode 1000pA. Keyframes were acquired every 400 nm at 
10 nm xy pixel size and a pixel dwell time of 2 µs. ROI imaging was performed at 3 or 5 nm 
xy pixel size and FIB milling was done every 10 or 50 nm. The total imaging time was set to 
be less than 2 min.  
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2.2.9.9 FIB-SEM post processing  
Images were inverted, cropped, aligned (Linear Stack Alignment with SIFT) and smoothed 
(smoothing function, 3x3 average) using FIJI (Schindelin et al., 2012). The 3D reconstruction 
was performed manually using Imod (University of Colorado Boulder, Boulder, U.S.A.). 
Counting of events in image stacks and quantification of object length were done in 





Chapter 3 Results  
3.1 Generation of an inducible MBP knock-out mouse model 
To investigate the role of myelin maintenance and turnover in the adult CNS a conditional 
myelin basic protein knock-out mouse line (Mbpfl/fl, internal line nomenclature MBPFLX) 
was generated. By selective knock-out of Mbp after developmental myelination the MBP 
potentially required for maintenance of the myelin sheath will be no longer synthesized. 
The lack of MBP could then be visualized by absence of compact myelin. New myelin 
membrane formed after knock-out should be MBP negative and not compacted. Mice harbor 
a floxed Exon 1 of the classical Mbp locus and were crossbred to mice heterozygotes for an 
inducible CreERT2 under the Plp promotor (internal line nomenclature PCET) (Leone et al., 
2003) (Figure 1-1, A). At the age of 8 weeks, a time point where myelination is considered 
mostly complete (Baumann and Pham-Dinh, 2001), mice were injected with 1 mg tamoxifen 
daily for 10 days with a two day break after 5 days to induce efficient recombination as 
described for this Cre driver line (Leone et al., 2003). The time point 0 weeks post tamoxifen 
injection (pti) was defined as the first day after the treatment was completed and mice were 
analyzed 8 to 52 weeks pti (Figure 3-1, B). Recombination of exon 1 was confirmed on DNA 
extracted from brain lysate 26W pti by polymerase chain reaction (PCR) with primer 
specific for the site of recombination (Figure 3-1, C).  
  
A) The MBPFLX mouse line was generated from embryonic stem cells obtained from EUCOMM that harbor a 
floxed Exon 1 of the classical Mbp locus. Mice were crossed to PLP-CreERT2 mice to allow inducible knock-out 
of MBP in adult oligodendrocytes. B) To induce knock-out of Exon 1, mice were injected for 10 days with 1 mg 








3.2 Decrease of Mbp mRNA after knock-out induction 
Mbp mRNA is packed into RNA granules and transported to the myelin sheath to be locally 
translated (White et al., 2008; Torvund-Jensen et al., 2014). Therefore, we expected a longer 
half-life compared to other myelin genes. To determine the knock-out efficiency, Mbp mRNA 
was quantified in total brain and total spinal cord lysate on 4 time points between 24 hours 
to 20 days after the first tamoxifen injection of the injection regime (Figure 3-2). Controls 
(Mbpflox/flox*PlpCreERT2 wt) were equally distributed within the sampled time points and pooled. 
Induced conditional knock-out mice (Mbpflox/flox*PlpCreERT2+, termed iKO) show a tendency 
towards an increase in mRNA levels 24h after the first injection. A similar effect was 
observed by Koenning and colleagues (Koenning et al., 2012) however the reason for this is 
unclear. Within 10 days the level of Mbp mRNA was decreased to 70% in brain and 50% in 
spinal cord compared to control. 20 days after first injection a reduction to 43% in brain 
and 23% in spinal cord was determined which was similar to expression levels detected at 
8W with 42% in brain and 14% in spinal cord (Figure 3-355, A, B). This indicates that 20 
days after the first tamoxifen injection the maximal reduction in Mbp mRNA levels was 
achieved and that the remaining transcripts could originate from non-recombined cells.  
 
Tamoxifen was injected for 10 days and mice were sacrificed at the indicated time points after first tamoxifen 
injection. A) mRNA extracted from brain and (B) spinal cord. N=3-4 animals, controls were time point matched 
and later on pooled. 20 days after first tamoxifen injection the levels of MBP mRNA reached baseline (Figure 
3-36) in brain and spinal cord. Each time point was compared to the pooled controls, expression was normalized 
to Rps13 and Ppia, two‐tailed unpaired t‐test; p < .05 (*), p < .01 (**), p < .001 (***)) Ctrl = control 








3.3 Ongoing expression of major myelin genes 
To determine whether the expression of other myelin genes is affected by the Mbp knock-
out, qPCR analysis of Golli, Plp1, Mag, Mog and Cnp was performed on brain lysate from 
animals 8, 16 and 26 weeks pti. None of these myelin gene transcripts were decreased in 
abundance. Instead, a trend towards increased mRNA abundance was seen in Plp1, Mag, 
Mog and Cnp at 26 weeks pti (Figure 3-3). Hence, the loss of Mbp expression in adult 
oligodendrocytes in the brain does not result in reduced expression of the other major 
myelin proteins.  
  
Despite knock-out of Mbp the expression of Golli transcripts, compact (Mag, Mog) and non-compact (Cnp) myelin 
genes are not decreased. A tendency for minor increase in mRNA abundance can be seen in Mag, Mog and Cnp 
at 26W pti. mRNA extracted from total brain lysate, N=4 animals per condition, expression was normalized to 
the housekeeping genes Rps13 and Ppia,, two‐tailed unpaired t‐test, p < .05 (*). 
 
Figure 3-3 The expression of PLP, Golli, MAG, MOG and CNP is not affected after MBP knock-out 
Results 
46 
3.4 Reduced abundance of major myelin proteins 
To address the effects of Mbp knock-out on the abundance of myelin proteins, immunoblot 
analysis was performed on total brain lysate of animal 8, 16 and 26W pti (Figure 3-4). At 
8W pti (Figure 3-4, A) a reduction in the abundance of MBP by 40%, PLP (20%) and MOG 
(35%) was observed (Figure 3-4, C). A further decrease in abundance at 16W pti of MBP by 
60%, PLP (40%), MOG (25%) and 26W pti of MBP by 75%, PLP (30%), MOG (30%) and MAG 
(35%) was found.  
Quantification of MBP showed that at 8W MBP was reduced to 62%, on 16W to 41% and on 
26W to 26%. A fitted exponential curve with one phase decay to model protein loss (Lüders 
et al., 2019) was calculated for the three time points (Y=(0,9669-0,08798)*e(-
0,06276*x) + 0,08798). Based on this equation the reduction of MBP by 50% was reached by 
approximately 11 weeks or 77 days. This is within range of half replacement times for MBP 
from Fornaserio et al. which ranged from 70 days in brain in a long pulse experiment to 82 
days in cortex and 101 days in cerebellum in shorter pulse experiments (Fornasiero et al., 
2018). In contrast to MBP the abundance of PLP, MAG and MOG were consistently decreased 
to about 70-80% of control at 8W, 16W and 26W pti.  
This shows that MBP is a very stable protein that persists many weeks after its synthesis in 
mature oligodendrocyte was abolished by the induced knock-out. The concomitant loss of 
the other compact myelin proteins indicates that knock-out of MBP affects myelin and 
results in a reduction of the whole compact myelin compartment. Fluorescent 
immunohistochemistry of MBP on brain sections at 26W pti showed reduced MBP signal in 
different CNS regions like the corpus callosum, the fimbria, the cerebellum and optic nerve, 





A-B) Immunoblot analysis of myelin proteins 8W pti (A) and 26W pti (B) shows a strong reduction in MBP 
protein abundance after 26W pti and to a lesser extent reduction in PLP, MAG and MOG levels. The loss of these 
myelin proteins is indicative for loss of the compact myelin compartment. Quantification is shown in (C). Total 
brain lysate, normalized to actin, N=3 animals, two‐tailed unpaired t‐test; p < .05 (*), p < .01 (**), p < .001 (***). 




Corpus callosum, fimbria (A), cerebellum (B) and optic nerve (C) in control and iKO mice 26W pti were 
fluorescently labeled for MBP and show less MBP signal in the iKO, scale bar 200 µm. 
  




3.5 Tremor and motor impairments occur months after MBP 
ablation 
The loss of MBP is accompanied by a slowly progressive development of a motor phenotype 
in male and female knock-out mice (Figure 3-6). Knock-out mice develop a tremor around 
20W pti that begins with subtle shivering during movement (tremor score 1), progressively 
increases between 30 and 35W pti towards tremor during resting (tremor score 2) and 
reaches its maximum with pronounced shivering (tremor score 3) around 40W pti. Later 
the tremor ceases as the mice age (Figure 3-6, B). The development of the tremor is 
accompanied by loss of body weight (Figure 3-6, A) and impaired motor functions (Figure 
3-4, C) as quantified by the capability of the mouse to leave a small box placed in the cage 
(Figure 3-4, D). IKO mice at 26W pti can leave the box with some difficulties due to hind 
limb weakness and therefore need more time for this task. Moreover, they are not able to 
jump out of the box like control mice and instead need to climb using their front legs. 
However, iKO mice are not as severely affected as the MBP mutant shiverer mice which 
suffer from a severe tremor and die prematurely by seizures within 10-12 weeks of age 




(A-C‘)Male and female knock-out mice show normal weight increase until 20-30 weeks pti. After that mice 
progressively lose weight (A, A’), develop tremor (B, B’) and show difficulties in leaving a plastic box which 
requires motor coordination and hind limb strength (C, C’ and D, D’). Tremor score: No tremor (0), tremor during 
movement like walking or climbing (1), tremor during resting (2). Box test: Leaving the box within 3 min with 
ease (0), leaving the box within 3 min with coordination problems (hanging on and falling over the edge), not 
leaving the box within 3 min (1) (Ctrl = control (Mbpflox/flox); iKO = induced conditional knock-out 
(Mbpflox/flox*PlpCreERT2) both conditions received tamoxifen. N=12 vs 12 male and 11 vs 11 female mice were 
scored bi-weekly, error bar represents SEM. 
  
Figure 3-6 Tremor assessment and development of body weight after knockout induction 
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3.6 Emergence and origin of non-compact membrane processes at 
the inner tongue 
The optic nerve is clearly affected by loss of MBP (Figure 3-5, C’) and was chosen as model 
tissue as it is a well-defined highly myelinated CNS white matter tract with the axons 
running mostly parallel and containing a limited amount of cell types. It can be dissected as 
intact fresh tissue and processed by HPF for excellent structural preservation or other 
sample preparation procedures for different analyses. To visualize structural changes of the 
compact myelin sheath induced by the abolishment of MBP synthesis, optic nerve samples 
were prepared for fine structural analysis by electron microscopy using high pressure 
freezing (HPF) and freeze substitution (FS).  
 
 
Analysis of myelin morphology 16W after MBP knock-out induction on an optic nerve cross section from a region 
close to the retina. The loss of MBP results in the formation of membrane tubules at the inner tongue. Where 
most of the compact myelin is lost membrane tubules loop out and form „myelin stacks“ leaving parts of the 
axon demyelinated. The non-compact myelin tubules can be seen disconnected from compact myelin in the 
vicinity of myelinated and non-myelinated axons (purple: axon, orange: membrane tubules). TEM micrographs 




Figure 3-7 Ablation of MBP results in formation of non-compact membrane tubules 
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When analyzing optic nerves 16W pti the following structural changes could be observed: 
At the adaxonal myelin site membrane structures emerge that massively enlarge the inner 
tongue (Figure 3-7). Occasionally, remnants of short myelin stretches with loop-like 
tubulations can be observed, which we called myelin-stacks (Figure 3-7, Myelin stack) that 
lay in close apposition to the axon covering it incompletely. These membrane processes 
have striking similarity to non-compact membrane processes seen in dysmyelinated tracks 
of shiverer mice (Figure 1-3) suggesting that they are oligodendrocyte derived membrane.  
 
Membrane tubules found at the inner tongue and in the surrounding of axons of MBP iKO mice are PLP positive 
(white arrow head) but lack MBP labeling (black arrow head) suggesting an oligodendrocytic origin. Optic nerve 
at 26W pti, 10 nm protein-A gold particles bound to primary antibody against PLP (custom made antibody A431) 
and MBP (Custom made antibody, Dr. Kathrin Kusch), scale bar 200 nm.  
To investigate whether these emerging membrane processes are myelin derived, 
immunogold labeling of the major myelin proteins MBP and PLP was performed. The 
membrane processes as well as the compact myelin are PLP positive as indicated by 10 nm 
gold particles (Figure 3-8, white arrowhead). The MBP labeling reveals that the compact 
myelin is clearly MBP positive, the observed membrane tubules at the inner tongue and also 
outside the axon are MBP negative (Figure 3-7, black arrow heads). From the clear presence 
of the myelin marker PLP it can be concluded that the membrane tubules are myelin-related 
membranes derived from oligodendrocytes. The absence of MBP indicates that this 
membrane is either aged myelin where MBP has been removed or myelin membrane that 
never contained MBP since it was newly synthesized after MBP ablation.  






Non-compact membrane tubules can be observed first at the inner tongue of the oligodendrocyte in MBP iKO 
mice. Quantification of tubule localization reveals that tubulation in the outer tongue is mostly associated with 
tubulation at the inner tongue. High pressure frozen and freeze substituted optic nerve,16W pti. N=4 iKO animal 
with at least 4 random sampled electron micrographs, One-Way Anova with Tukey's multiple comparisons test, 
scale bar 500 nm. 
 
  
Figure 3-9 Membrane tubules occur predominantly at the inner tongue 
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To assess whether the observed phenotype first occurs at the inner or the outer tongue the 
occurrence of non-compact myelin membrane tubules was assigned to either inner tongue, 
outer tongue or both locations and quantified in high pressure frozen optic nerve at 16W 
pti (Figure 3-9). This assessment showed that myelin membrane tubules occur mostly at 
the inner tongue. Some tubules were localized adjacent to the axon but due to limitations of 
the 2D image representation those are indistinguishable from the outer tongue. In many 
cases myelinated profiles showed myelin tubules at the inner tongue and similar membrane 
structures outside of the myelin sheath (termed inner and outer tongue) (Figure 3-9). Since 
outer tongue membrane tubules have not been observed independently of an inner tongue 
phenotype, we consider the inner tongue as site of first emergence of these myelin tubules. 
The observed outer tongue phenotype is considered a secondary effect following the initial 




3.7 Loss of myelinated profiles and decreased myelin thickness  
To investigate the formation of these observed inner tongue tubules in more detail (Figure 
3-7) electron micrographs of high pressure frozen optic nerve samples at 8W, 16W and 26W 
pti were analyzed and showed the progressive phenotype of myelin loss, increase in 
unmyelinated axons as well as phenotypic axons with inner tongue membrane processes or 
myelin stacks (Figure 3-10, A). Sample preparation by high pressure freezing is an excellent 
tool for close to native tissue preservation and assessment of myelin phenotypes (Möbius 
et al., 2016) Here this technique facilitated the identification of the phenotype and 
differentiation between non-myelinated axons and other cellular processes from astrocytes 
or microglia (Möbius et al., 2016). In this case HPF material was used to validate that the 
observed larger round processes are non-myelinated axons. 
For statistical analysis chemically fixed material was used to allow a representative 
sampling over the total cross section of an optic nerve, which is not possible in HPF-
prepared samples due to freezing artifacts in some areas of the tissue. In micrographs of the 
optic nerve at 8W pti approximately 60% of all axons per field of view are normally 
myelinated, 20% show membrane processes at the inner tongue and 10% are non-
myelinated. In comparison in control animals approximately 90% of axons are normally 
myelinated and 7% are non-myelinated (Figure 3-10, B). The number of myelinated fibers 
further decreases at 16W and 26W pti with a concomitant increase in the number of non-
myelinated fibers. The percentage of axons that show a phenotype including enlarged 
membrane tubules at the inner tongue or presence of myelin stacks deceased from 
approximately 25% (8W pti) to 5% (52W pti).  Interestingly, axonal loss was not observed 
in any analyzed time point (Figure 3-10, B).  
Loss of myelin was also observed in other myelinated tracts of the CNS. At 26W pti the 
density of myelinated fibers was decreased in optic nerve, caudal corpus callosum (cCC) and 
the corticospinal tract of spinal cord (SC CST). The relative reduction of myelinated fiber 
density was highest in optic nerve (55% reduction) followed by SC CST (40%) and the least 
affected caudal corpus callosum (30%) (Figure 3-11, A). When analyzing the progression of 
the demyelination in the SC CST the myelinated axon density showed a high variation and 
no significant reduction at 16W pti, but a decreased density at 26W pti (40% reduction) 




(A) Transmission electron micrographs of optic nerve (HPF) reveal the emergence of non-compact myelin 
structures (red arrow head), loss of compact myelin (orange arrow head) and an increase in non-myelinated 
axons. (B) Quantification of all axons per field of view (FOV) reveal that the percentage of normally myelinated 
axons is progressively decreasing while axons with phenotypic membrane processes and membrane stacks as 
well as unmyelinated axons are proportionally increasing. No axonal loss of was observed. Analysis was 
performed on chemically fixed (K&S) cross sections in the retinal part of the optic nerve of at least 5 random 
sampled micrographs with a total area of> 330 µm² and > 200 axons per animal. N= 3-4 animals, two‐tailed 
unpaired t‐test, p < .05 (*), p < .01 (**), p < .001 (***) scale bar 1 µm. 
 




Decreased density of myelinated axons was observed in different parts of the CNS including optic nerve (n.opt), 
caudal corpus callosum (cCC) and the corticospinal tract of the spinal cord (CST) (A). Heterogeneity in the loss 
of myelinated profiles can be observed between regions with the strongest reduction seen in N.opt followed by 
SC CST and cCC. (B) Density of myelinated axons is decreased in SC CST 26W pti and 52W pti. Analysis was 
performed on cross sections in the retinal part of the optic nerve, the caudal corpus callosum and the CST of the 
spinal cord of at least 5 random sampled micrographs with a total area of > 330 µm² and > 200 axons. N= 3-4 
animals, two‐tailed unpaired t‐test, p < .05 (*), p < .01 (**), p < .001 (***). 
 
To asses not only effects of MBP iKO on the number of myelinated profiles, but also on the 
thickness of the myelin sheath, measurements of a corrected g-ratio were performed. Due 
to the previously described enlargement of the inner tongue, a conventional g-ratio 
assessment would result in a skewed representation of compact myelin thickness since 
inner tongue and compact myelin are usually not considered separately. To avoid this, the 
area of the inner tongue was subtracted from the complete fiber area before deriving the 
diameter assuming a circular area. The corrected g-ratio was calculated without the inner 
tongue by dividing the calculated diameter of the compact myelin by the calculated 
diameter of the axon. (Figure 3-12, A).  




Corrected g-ratio in optic nerve 8W pti (A), 16W pti (B) and 26W pti (C) was increased over the whole range of 
axonal calibers. At least 150 axons per animal and N= 3-4 animals were analyzed. Linear regression line (black 
control, orange iKO) To correct for non-compact myelin enlargement the inner tongue area was subtracted from 
the total fiber area and a corrected diameter was calculated. The resulting diameter was then divided by the 
axonal diameter to obtain a corrected g-ratio. Unmyelinated axons were excluded from the analysis. 
 
A cloud upshift for the corrected g-ratio was observed for axons in the optic nerve 8W, 16W 
and 26W pti (Figure 3-12, B-D). This showed that in addition to in the reduced number of 
myelinated axon profiles a reduction in myelin thickness can be observed after ablation of 
MBP. In contrast, no reduction in corrected g-ratio has been observed in axons of the spinal 
cord (Figure 3-12, A) or the corpus callosum (Figure 3-12, B) 26W pti.  




Corrected g-ratio in CST of spinal cord (A), and rostral corpus callosum (B) 26W pti. In the CST (B) and corpus 
callosum (B) no change in corrected g-ratio is observed. At least 150 axons per animal and N= 3-4 animals were 
analyzed and a linear regression was plotted (black control, orange iKO). 
  
Figure 3-13 Corrected g-ratio in spinal cord and rostral corpus callosum 
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3.8 No obvious ultrastructural changes in PNS and in the absence 
of tamoxifen  
To test whether the motor phenotype described earlier (Figure 3-6,  B,C) is a consequence 
of demyelination in the peripheral nervous system, electron micrographs of sciatic nerve 
16W pti were analyzed. Obvious myelin abnormalities could not be observed. (Figure 3-14) 
This is in accordance with previously published work showing that shiverer PNS myelin 
shows minor alterations such as a few layers of uncompact myelin in the inner tongue and 
an increased number of Schmidt-Lantermann incisures (Rosenbluth, 1980; Gould et al., 
1995), but is otherwise functional (Privat et al., 1979; Uschkureit et al., 2000). 
 
Ablation of MBP at 8 weeks of age does not result in obvious myelin abnormalities at 16W pti. Transmission 
electron micrograph of sciatic nerve, scale bar 1µm. 
 
  




Myelin appears normal in animals that harbor Mbpflox/flox*PlpCreERT2 but have not received tamoxifen. Electron 
micrograph of high pressure frozen (HPF) and freeze substituted (AFS) optic nerve at an age of 36W, scale bar 
500 nm. 
 
To verify that recombination and resulting structural changes do not appear without 
induction Mbpflox/flox*PlpCreERT2+ mice that did not receive tamoxifen were inspected by 
electron microscopy. The optic nerve of mice at 36W of age, which is the matching age for 
mice at 26W post tamoxifen induction showed no myelin abnormalities and or increased 
membrane tubules at the inner tongue (Figure 3-15). From this we concluded that the 
observed motor phenotype can be attributed most likely to the loss of MBP in the CNS and 
the resulting demyelination. 
 
3.9 MBP has little lateral mobility within the myelin sheath  
Next, we addressed the question whether MBP is selectively lost from the myelin sheath or 
the compact myelin compartment itself is shrinking. Immunoblot analysis at 26W pti from 
brain lysate (Figure 3-16, A) and the isolated myelin from the same lysate (Figure 3-16, D) 
showed that MBP and PLP abundance was decreased only in the lysate but not in the myelin 
fraction (Figure 3-16, E). The reduced levels of MBP and PLP in the lysate indicate a reduced 
myelin yield from iKO brains (Figure 3-16, B, C). From these data we concluded that the 
abundance of the compact myelin compartment per se is reduced in knock-out animals and 
that the enriched compact myelin fraction is defined by and dependent on presence of MBP. 
This finding also implies that MBP has little lateral mobility, since the composition of the 
remaining myelin is unchanged regarding MBP and PLP abundance. To test this hypothesis 
at the ultrastructural level, MBP immunogold labeling was performed on optic nerve 
cryosections from mice at 26W pti. The area covered by compact myelin was significantly 
reduced by 50% (Figure 3-17, A) which is in accordance with the previously described 
decrease in myelinated profiles in the optic nerve (Figure 3-10, B). The density of MBP 
labeling gold particles was unchanged on compact myelin in knock-out animals in 
comparison to controls. This is indicating that the abundance of MBP within the compact 
myelin was indeed unchanged as expected (Figure 3-17, B). From these experiments we 
conclude that MBP has limited lateral mobility and is not diluted out of the compact myelin 
after Mbp ablation.  




MBP and PLP levels are diminished in immuno-blot of total brain lysate from mice 26W pti (A) changes in 
abundance are not found in the isolated myelin fraction (B, C). The amount of compact myelin is decreased by 
approximately 50% in iKO compared to control mice as measured by Bradford protein assay (Bio-Rad) (D) and 
myelin mass is reduced in the second sucrose gradient step in the myelin isolation protocol (E). Brain lysate 
from one hemisphere was used for myelin isolation, two‐tailed unpaired t‐test; p < .05 (*). 
 




The labeling density of MBP in control myelin (A) is comparable to iKO myelin (B) suggesting little reduction in 
MBP content within the compact myelin of iKOs (D). The section area occupied by myelin is significantly 
decreased after MBP iKO (C). Labeling of MBP with a custom-made antibody (Kathrin Kusch), 10nm protein-A-
gold particles. At least 4 sections with in total 300µm2 per animal were quantified using a 2 µm grid to randomly 
select axons, N=3-4 animals, two‐tailed unpaired t‐test; p < .05 (*) scale bar 500 nm.  
  
Figure 3-17 MBP has limited lateral mobility within the myelin sheath 
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3.10 Proteom analysis of the optic nerve after MBP iKO  
To study changes in myelin composition and systemic responses after ablation of MBP, 
mass-spectrometry measurements and statistical evaluation were performed by the team 
of Dr. Olaf Jahn (Proteom Facility, Max-Planck-Institute for Experimental Medicine). Since 
the myelin fraction would mostly enrich compact parts of the myelin but , judging from the 
discussed unchanged MBP content in the enriched myelin fraction, probably not the 
observed non-compact membrane tubules (Figure 3-16) the optic nerve lysate was chosen 
as the model of choice. The optic nerve can be isolated easily and reproducibly in toto and 
represents a model-white matter tract with a limited amount of cell types. Whole optic 
nerve lysates from MBP iKO and control animals 8W, 16W and 40W pti as well as shiverer 
and control mice at an age of 10 weeks were analyzed. We included shiverer optic nerves 
into the analysis to be able to assess similarities and differences between the demyelinating 
model of the induced MBP ablation and the model that never possessed MBP. 
 
 
Optic nerve lysate from male MBP iKO at and 10W old shiverer were subjected to mass spectrometry (N=4). High 
abundant proteins such as MBP and PLP were quantified using the MSE approach, for less abundant proteins the 
more sensitive HDMSE method was used. Mass-spectrometric measurements were performed by the team of Dr. 
Olaf Jahn at the Max-Planck-Institute of Experimental Medicine as previously described (A). Silver staining of 
proteins in polyacrylamide gels of optic nerve lysate 40W pti and 10W old shiverer was performed as quality 





Figure 3-18 Proteom analysis of optic nerve lysate 
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To quantify the top abundant myelin proteins such as MBP, PLP or CNP measurements were 
performed in the MSE mode, which allows precise quantification of highly abundant 
proteins. For quantification of lower abundant proteins samples were measured in high 
definition mass spectrometry (HDMSE) acquisition mode which enables the detection of low 
abundant peptides but yields less precise abundance measurements for higher abundant 
peptides (Figure 3-18, A). To verify sample quality silver staining of proteins in 
polyacrylamide gels were performed for every sample exemplary shown for 40W pti and 
shiverer. (Figure 3-18, B). Vulcano plots of Log2 fold changes and q-values showed many 
proteins significantly changed in abundance and revealed an expected distribution 
validating the quality of the data (Figure 3-19). The relative protein abundance as measured 
by MSE showed a progressive shift in lysate composition. Major myelin proteins like MBP, 
PLP, and CNP were progressively less represented in the complete protein amount 
reflecting a reduction of the compact myelin compartment (Figure 3-20). 
 
Vulcano plots of HDMSE measured with Top 15 most significantly regulated genes labeled. Number of detected 
proteins 8W (1500), 16W (1447), 40W (1644) and shiverer (1677). Dashed line: q-Value = 0.05. q-Value was 
calculated using the LIMMA package and performed by Lars Piepkorn (Proteom facility, Max-Planck institute for 
Experimental Medicine)   




Top 25 most abundant proteins as found in control at 8W pti. Data obtained by MSE and plotted as percent of 
total protein amount as quantified by Isoquant. Tubulin isoforms could not reliably be distinguished and were 
pooled. Spectrins were excluded due to unreliable quantification for technical reasons. 
 
The loss of MBP by ablation in the adult myelinated animal in Mbpflox/flox*PlpCreERT2 + or the 
complete absence of MBP in the shiverer mice results in major changes in protein 
composition. A q-value threshold of <0.05 was set to determine significant changes resulting 
in an increase of abundance for 176 proteins and a decrease for 565 proteins in nerve lysate 
8W pti. At 16W pti 250 proteins were found to be increased and 234 were decreased 
followed by 878 increased and 351 decreased proteins in optic nerve lysate 40W pti. The 
highest number of changed proteins was found in shiverer optic nerve lysate with 389 
proteins decreased and 1034 significantly increased in abundance compared to the control.  
The proteins most significantly decreased in abundance for 8W and 16W pti (Figure 
3-21, A ,B) include for example myelin proteins such as MBP, CD9 and Opalin, proteins 
associated to lipid synthesis such as farnesyl diphosphate synthase (FPPS) or UDP 
glycosyltransferase 8 (CGT) and adhesion proteins like protein 4.1, CD81 or neural cell 
adhesion molecule 1 (NCAM1). Increased in abundance are proteins associated with lipid 
transport such as APOD and APOE, proteins of the cytoskeleton like ADP-ribosylation factor 
2 and 4 (ARF2/4), fascin (FSCN1) or tubulin (TBAL3) and proteins associated with stress 
response such as glutathione S-transferase P 1 (GSTP1) or alpha-crystallin B chain (CRYAB).  
For 40W pti the top proteins significantly reduced in abundance include myelin proteins 
like MBP, PLP (MPYR), MOG, MAG, CN37 (CNP) and Opalin and cell adhesion molecules like 
tetraspanin 2 (TSN2) and CD82. The proteins most increased in abundance are microglial 
and degradative proteins such as hexokinase B (HEXB), cathepsin D/Z/S (CATD, 
CATZ,CATS), components of the complement system (C1QC; C1QB) and components of the 
cytoskeleton such as vimentin (VIM) alpha actinin-1 (ACTN1) and actin-related protein 2/3 
complex subunit 1B (ARC1B) (Figure 3-21, C). 
 In shiverer the top 25 proteins significantly reduced in abundance are mostly myelin 
proteins such as MOG, PLP (MYPR), claudin11 (CLD11), MAG and cytoskeletal proteins like 
anilin (ANLN), septin 2 and 4 (SEPT2/4). Increased in abundance are ribosomal proteins 
such as 60S ribosomal protein L4/L7a/L5 (RPL4/7a/5) lipid associated proteins such as 
Figure 3-20 Relative protein composition shows reduction in major myelin proteins 
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APOE, long-chain-fatty-acid--CoA ligase (ACSBG1), fatty acid-binding protein (FABP7) and 
energy metabolism related proteins such as phosphoglycerate mutase 2 (PGAM2), creatine 
kinase B-type (KCRB) and ATPase subunit alpha-1 (AT1A1) (Figure 3-21, D) 
 
 
(A-D) Top 25 significantly increased and decreased proteins in optic nerve lysate from iKO and control mice 8W, 
16W and 40W pti and from shiverer and control at the age of 10W. Proteins with reduced abundance include for 
example myelin proteins (MBP, MPYR (PLP), MAG, MOG), proteins of the cytoskeleton (ANLN, SEPT), cell 
adhesion molecules (tetraspanin 2, (TSPAN2), CD9, NCAM1) and lipid synthesis (farnesyl diphosphate synthase 
(FPPS), UDP glycosyltransferase 8 (CGT). Proteins with increased abundance include for example lipid transport 
proteins (APOD, APOE), degradative enzymes (cathepsin D (CATD) and Z (CATZ)), cytoskeleton associated 
proteins (ARF2, ARF4) and marker for microglia (hexokinase B (HEXB)) and astrocytes (aquaporin 4(AQP4)). 
Mean of Log2 Fold change of 4 technical replicates per animal, plotted on a color scale with red represening 
enrichment and blue deminishment in iKO compared to control. Protein identifies represent Uniprot protein IDs 
of mus musculus. 
  
Figure 3-21 Top 25 significantly increased and decreased proteins in optic nerve  
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Pathway enrichment analysis was performed on proteins significantly increased in 
abundance with a q-Value threshold of less than 0.05. Analysis of the early time point 8W 
pti, the late time point 40W pti and shiverer animals was performed and mapped on KEGG 
pathways using the freely available web tool g-profiler (https://biit.cs.ut.ee/gprofiler). 
KEGG pathway analysis revealed an enrichment of proteins assigned to mitochondrial 
processes such as oxidative phosphorylation or the TCA cycle and for proteins associated 
with ribosomes (Figure 3-22, A-C). In samples of 40W pti and shiverer an enrichment was 
found for proteins associated with glycolysis and degradative processes such as the 
proteasome and the phagosome (Figure 3-21 B,C).  
 
 
(A-C) Top 20 enriched KEGG pathways in optic nerve lysate 8W pti, 40W pti and 10W old shiverer reveals 
enrichment in mitochondrial processes (Oxidative phosphorylation, TCA cycle) and proteins associated to the 
ribosome (A, B, C). For 40W pti and shiverer enrichment of glycolysis related proteins and proteasome pathway 
are found (B, C). Enrichment was statistically corrected by the g:SCS threshold as given by g-profiler. Enrichment 
analysis was performed against the mus musculus background provided in g-profiler. 
 
In summary the proteome analysis reveals a large number of proteins significantly changed 
in abundance of which the most interesting ones belonging to the group of stress related 
proteins, the increase in mitochondrial proteins and cell adhesion as well as cytoskeletal 
proteins across all 4 conditions. The datasets are available as a resource for future analysis. 
Figure 3-22 Pathways enrichment of proteins with significantly increased abundance 
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3.11 Lipid analysis of optic nerve after MBP iKO  
Changes in lipid composition were reported in white matter of an experimental 
autoimmune encephalomyelitis model of marmosets (Ohler et al., 2004). White matter 
lesions contained increased levels of phosphatidylserine and unsaturated fatty acids 
including cholesterol esters. The levels of sphingomyelin, phosphatidylcholine, and 
cerebroside sulfates were decreased. These changes were hypothesized to increase 
membrane fluidity and curvature resulting in reduced adhesion of MBP resulting in 
formation of membrane vesiculations (Ohler et al., 2004). Based on the previously 
published results we investigated the lipid composition after knock-out of Mbp. 
Lipid analysis by mass spectroscopy of optic nerves and corpus callosum 8W and 16W pti 
was performed in collaboration with Prof. Dr. Britta Brügger (Biozentrum Heidelberg) to 
study the consequences of Mbp ablation on the lipid composition (Figure 3-23). A minor 
reduction of cholesterol (Chol) levels was observed in optic nerve 8W pti (Figure 3-21, A) 
and a comparable non-significant trend in corpus callosum 8W pti (Figure 3-21, C). Levels 
of lyso-phosphatidyl choline (LPC) were increased in corpus callosum and optic nerve 8W 
pti and showed a non-significant trend towards increase 16W pti (Figure 3-21. A-D). Levels 
of phosphatidylglycerol (PG) were increased in corpus callosum 8W and 16W pti and 
showed a strong but due to high variation non-significant increase in optic nerve 16W pti. 
For phosphatidylserine (PS) a minor increase is observed in corpus callosum 8W and 16W 
pti. Furthermore, a strongly significant increase of phosphatidylinositol (PI) levels was 
observed for optic nerve 16W as well as a non-significant increase in corpus callosum 16W 
pti. The abundance of cholesteryl ester (CE) showed a trend towards decrease in corpus 
callosum 8W pti and in optic nerve 8W and 16W pti. Since the lipid analysis was performed 
on heterogeneous tissue samples, we are not sure about the interpretation of these results. 
It is possible that too many cell types with their cell-type specific responses were contained 
in the sampled area. On the other hand, we did not expect to find differences in the myelin 




Lipid composition analysis by mass spectrometry of optic nerve 8W pti (A), 16W pti (B) and corpus callosum 
8W pti (C) and 16W pti (D) reveal minor changes in lipid composition after MBP knock-out. Lipids: Cholesteryl 
ester (CE), Ceramide (Cer), Cholesterol (Chol), Lyso-Phosphatidyl Choline (LPC), Phophatidic acid (PA), 
Phosphatidylcholine (PC), Phosphatidylethanolamine (PE), Phosphatidylglycerol (PG), Phospatidylinositol (PI), 
Phospatidylserine(PS), Sphingomyelin (SM). N=4 samples obtained from individual animals. two‐tailed 
unpaired t‐test, Lipid analysis was performed by the team of Prof. Dr. Britta Brügger (Biozentrum Heidelberg). 
 
3.12 Microglial activation and astrogliosis upon MBP iKO  
Since demyelination is known to trigger inflammation (Peterson and Fujinami, 2007), 
analysis of the neuropathological markers GFAP, MAC3, APP and CD3 was performed. 
Immunohistochemistry on fimbria was carried out for the time points 8W, 16W, 26W and 
52W pti and for the corticospinal tract (CST) of the spinal cord at the time points 8W, 16W 
and 26W pti. An increase in GFAP+ area indicating an astrogliosis was first observed 16W 
pti together with an increase in CD3 positive immune cells and a minor increase in MAC3+ 
area indicating the onset of a microgliosis (Figure 3-24, A- C). At 26W pti the MAC3+ area is 
increased and APP positive spheroids are present (Figure 3-24, A- D). Astrogliosis and the 
number of CD3+ cells persist and the number of APP spheroids and MAC3+ area is further 
increased at the late time point at 52W pti.  
  




An increase in GFAP+ area (A) indicates astrogliosis beginning between 8 and 16W pti (A’). The increase of 
MAC3+ area (B) indicates increasing microglial activity beginning between 8 and 16W pti and increasing until 
52W pti (B’). Axonal pathology observed by labeling of APP spheroids (C) appears late at 26W pti and increases 
until 52W pti (C’). Increased numbers of T-cells (D) can be observed already at 16W pti. showing immune system 
activation (D’). N=3-5 animals, 2 fimbria (GFAP, MAC3, APP) or 6 (CD3) fimbria per animal, two‐tailed unpaired 
t‐test; p < .05 (*), p < .01 (**), p < .001 (***), scale bar 50 µm. 
 
  
Figure 3-24 Progressive low grade astrogliosis, microgliosis and axonal pathology in Fimbria 
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Neuropathological analysis of the spinal cord corticospinal tract (CST) at 8W, 16W and 26W 
pti was performed by immunohistochemistry of GFAP, MAC3 and APP (Figure 3-25, A-C). In 
spinal cord a significant increase in GFAP+ area was first observed 26W pti while a beginning 
microgliosis is already detected at 16W pti (Figure 3-25, A, B). In contrast to the fimbria a 
significant increase in APP spheroids was observed as early as 8W pti and further increased 
at 16W and 26W pti.  The rather late onset of astrogliosis and microgliosis with limited 
severity indicates that this mouse model is a suitable tool to study myelin maintenance in a 
relatively unperturbed physiological system with only minor inflammation.  
 
An increase in GFAP+ (A) and MAC3+ (B) area in the corticospinal tract (CST) of spinal cord at 26W pti shows 
astrogliosis(A’) and microgliosis (B’) Axonal pathology as observed by labeling of APP spheroids (C’) appears 
already at 16W pti and is further increased at 26W pti (C’).N=3-5 animals, analysis of CST of at least 2 sections 
per animal, two‐tailed unpaired t‐test; p < .05 (*), p < .01 (**), p < .001 (***), scale bar 50 µm. 
  
Figure 3-25 Progressive low grade astrogliosis, microgliosis and axonal pathology in the spinal cord 
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3.13 Increased density of oligodendrocyte after MBP iKO  
To exclude that the observed inflammation and loss of myelin is caused by oligodendrocyte 
death, the number of oligodendrocytes and the occurrence of cell death were analyzed in 
the fimbria. A terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay 
was performed and no significant changes in the number of apoptotic cells were found in 
fimbria of iKO compared to control animals 40W and 52W pti (Figure 3-26).  
To investigate oligodendrocyte and OPC cell numbers and proliferation in response to 
myelin loss we treated mice at the peak of clinical symptoms (40W pti) with 0.2 mg/ml of 
the thymidine analogue 5-ethynyl-2´-deoxyuridine (EDU) in drinking water. During cell 
division EDU is integrated into replicating DNA, effectively tagging dividing cells and 
allowing the identification of cells that underwent cell division during EDU administration 
(Cavanagh et al., 2011). Mice were treated for three weeks and sacrificed after an additional 
three-week chase period to be able to observe the differentiation of EDU labeled cells. The 
number of oligodendrocytes after MBP iKO in the fimbria was assessed by 
immunohistochemistry of the oligodendrocyte linage marker Olig 2 (Figure 3-27, A), the 
mature oligodendrocyte marker Carboanhydrase 2 (CAII) (Figure 3-27, B) and the 
oligodendrocyte precursor marker PDGFR A (Figure 3-27, C). Double labeling with EDU 
reveals a four-fold increase in Olig 2+ EDU+ as well as in PDGFR A+ EDU+ double positive 
cells. A similar but non-significant trend was observed for CAII+ EDU+ positive cells (Figure 
3-27, A’-C’). The density of Olig 2, CAII and PDGFR A positive cells was increased (Figure 
3-27, D) 46W pti while the area of the fimbria was not significantly changed (Figure 3-27, E). 
The increase in CAII+ cells was consistently found in fimbria of animal 26W, 46W and 52W 
pti (Figure 3-27, F).  
 
 
A TUNEL cell death assay was performed to test for increased cell death in the fimbria of iKO animals showed 
no significant increase in tunnel positive cells 40W and 52W pti. Chromogenic labeling, N= 3-4 animals, 2 fimbria 
per animal, two‐tailed unpaired t‐test, scale bar 100 µm. 







A-C) To study proliferation of the oligodendrocyte linage cells, mice at 40W pti were treated with 0.2mg/ml EdU 
in drinking water for three weeks followed by a three weeks chase period to allow cell maturation of labeled 
cells. Immunohistochemistry of cells positive for EDU+ and oligodendrocyte linage marker Olig 2 (A), the mature 
oligodendrocyte marker CAII (B) or the OPC marker PDGFR A (C) were quantified in fimbria and show an 
increase in EDU+ Olig 2+ and EDU+ PDGFR A+ double positive cells (A’,C’). (D-E) The densities of Olig 2, CAII and 
PDGFR A+ cells were increased 46W pti (D) while the fimbria area was not significantly decreased (E). (F) 
Quantification of CAII+ cells at 26W, 46W and 52W pti revealed a consistent increase in CAII+ cells at after adult 
MBP iKO. (A’, B’, C’: Percentage of EDU positive cells from Olig 2/CAII or PDGFRA positive cells per FOV) N= 4 
animals, two‐tailed unpaired t‐test; p < .05 (*), p < .01 (**), p < .001 (***), scale bar 50 µm.  
 
From these data showing that oligodendrocyte numbers are not reduced, but proliferation 
rate and numbers are slightly increased we concluded that the induced Mbp ablation and 
the resulting loss of MBP do not cause widespread oligodendrocyte death. MBP is not 
required for survival in mature oligodendrocytes that differentiated in the presence of MBP 
before the induced knock-out. 
 
3.14 Cholesterol synthesis is affected on tissue level but not in 
oligodendrocytes 
The corpus callosum is another well-defined myelin tract in the CNS and was previously 
chosen for Lipidome analysis. Determination of astrocytic, microglial and oligodendrocyte 
genes was performed to assess demyelination and inflammation. The kinetics of myelin loss 
characterized by the decrease in myelinating profiles appeared slower in corpus callosum 
therefore late time points at 40W and 52W pti were chosen for this analysis. Both time 
points showed an increase in the microglial markers lysosomal associated membrane 
protein 2 (Lamp 2) and allograft inflammatory factor 1 (Aif1) as well as in astrocyte markers 
such as glial fibrillary acidic protein (Gfap), aquaporin 4 (Aqp4) and S100 calcium binding 
protein B (S100b) which are evidence for microgliosis and astrogliosis (Figure 3-28,  A) A 
reduction of MBP expression by approximately 50% together with an increased expression 
of carbonic anhydrase 2 (Car2), platelet derived growth factor receptor alpha (Pdgfr A) and 
Plp1 is indicative for continuous presence of recombined oligodendrocytes as well as an 
increased number of OPCs. (Figure 3-28, B).  




(A) qRT-PCR analysis of corpus callosum 40W and 52W pti reveals an increase in astrocyte and microglial 
markers (B) Expression of Mbp mRNA is reduced to 50% of control while the expression of PLP and Olig 2 is 
unchanged. The OPC marker PDGFR A and the mature oligodendrocyte marker CAII show increased expression 
at 52W pti. (C) Expression of genes involved in cholesterol synthesis are decreased by approximately 20% while 
Apod, a gene involved in cholesterol transport is increased 52W pti. Controls from 40W and 52W pti were 
pooled, expression was normalized to Rps13 and Rplp0, N=4-5 animals, two‐tailed unpaired t‐test. 
 
The synthesis of cholesterol is an essential and rate limiting step for myelination and 
ablation of cholesterol synthesis in oligodendrocytes leads to delayed CNS myelination 
(Saher et al., 2005). Lipidome results showed only minor reduction in cholesterol 
abundance after ablation of Mbp. To assess whether cholesterol synthesis was reduced 
potentially affecting normal steady state myelin maintenance we tested for changes in genes 
belonging to the cholesterol synthesis pathway. While the expression of the rate limiting 
enzyme 3-hydroxy-3-methylglutaryl-CoA reductase (Hmgcr) was not significantly changed 
other genes involved in cholesterol synthesis such as squalene synthase (Fdft1), 24-
dehydrocholesterol reductase (Dhc24) and cytochrome P450 Family 51 (Cyp51) were 
decreased in expression by approximately 20%. At the same time cholesterol transport 
Figure 3-28 Decreased cholesterol synthesis in corpus callosum 52W pti 
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genes such as apolipoprotein D (Apod) showed and increased expression 52W pti while 
apolipoprotein E (Apoe) was unchanged (Figure 3-28, C).  
To differentiate whether the decreased expression of cholesterol synthesis genes was 
attributed to oligodendrocytes magnetic cell isolation (MACS) of O4 positive cells from 
corpus callosum 16W pti was performed in collaboration with Lena Spieth, Stefan Berghoff 
and Tim Düking (AG Dr. Gesine Saher, Max-Planck-Institute for Experimental Medicine). For 
expression analysis RNA was extracted from isolated cells and cDNA amplification by single 
primer isothermal amplification (SPIA) was performed and followed by qRT-PCR (Figure 
3-29, A). The expression of myelin and oligodendrocyte genes other than Mbp was not 
reduced in isolated oligodendrocytes (Figure 3-28, B) with Mag showing a trend towards 
increased expression that is consistent with expression analysis on whole brain lysate 
(Figure 3-3). Analysis of genes involved in cholesterol biosynthesis revealed no significant 
change in expression of sterol regulatory element-binding protein 2 (Srebp2), Hmgcr, Fdft1, 
Shc24, Cyp51 and Fdps (Figure 3-28, C). Furthermore, genes involved in cholesterol 
including Apoe, Apod and low density lipoprotein receptor (Ldlr) were not changed in 
isolated oligodendrocytes (Figure 3-28, D). From these data it can be concluded that in 
oligodendrocytes the expression of major cholesterol synthesis genes is not affected by Mbp 
ablation.  
 
(A) Magnetic cell sorting and isolation of O4+ cells including oligodendrocytes and OPCs from corpus callosum 
of mice 16W pti. Isolation was performed in collaboration with Lena Spieth, Stefan Berghoff and Tim Düking (B) 
qRT-PCR analysis reveals that isolated O4+ cells have a reduced Mbp expression but not significantly altered 
expression of other myelin and oligodendrocyte proteins. (C) Major proteins of the cholesterol synthesis 
Figure 3-29 Isolated O4+ cells show no decrease in cholesterol synthesis genes 
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pathway are unchanged with a tendency to increased expression in O4+ cells. (D) Cholesterol transport genes in 
O4+ cells were not significantly changed. N=5 Corpora callosa obtained from individual animals, expression was 
normalized to Rps13 and Rplp0 used as housekeepers , two‐tailed unpaired t‐test. 
To summarize, the inducible MBP knock-out mouse model fulfills all requirements to study 
myelin maintenance and turnover in the adult CNS. Low levels of inflammation, absence of 
widespread oligodendrocyte death and ongoing synthesis of cholesterol synthesis genes as 
well as myelin genes allows to study ongoing myelin turnover in a mostly unperturbed state. 
Reductions in myelin proteins, myelinated profiles and compact myelin thickness indicated 
a slowly progressive loss of compact myelin. 
 
3.15 Internodal shortening after MBP iKO  
To understand the replacement of compact myelin by tubular membranes and the increased 
number of unmyelinated axons we investigated the structure of individual myelin 
internodes. 2D TEM cross sections allow to study changes in the axonal population by 
quantification of many axons and myelin profiles in nerve cross sections. However, the 2D 
images does not reveal at which position along the internode the axons were sectioned. The 
localization of the section plane within the long myelin internode as for example the 
distance of the section plane to the node of Ranvier cannot be determined by 2D EM. To 
study changes in morphology along internodes of individual axons we used 3D volume 
electron microscopy (FIB-SEM). 
3D reconstruction and visualization revealed that the observed inner tongue membrane 
processes are tube-like structures connected to the myelin sheath that can extend several 
µm away from their axon (Figure 3-30, A, yellow arrow heads). Reconstruction also revealed 
that the percentage of the surface of the axons covered by myelin is reduced after ablation 
of MBP to approximately 75% at 16W pti and 30% at 26W pti (Figure 3-30, C). This is also 
reflected by a progressive reduction in myelinated profiles as quantified on transmission 
electron micrographs of optic nerve cross sections 8W, 16W, 26W, 40W and 52W pti (Figure 
3-36, B). These data show that myelin in the optic nerve disappears by shortening of the 
internodes leaving naked axons behind after ablation of MBP in mature oligodendrocytes. 
Using the density of myelinated axons on a cross section of the optic nerve, we estimated 
the time after which 50% of the myelin profiles were lost showing a shortening of the 
internode by half. The following calculations represent estimates based on the assumption 
that the shortening of myelin internodes underlies a linear reduction through a shortening 
or retraction process. At 8W pti the number of axons between control and iKO did not 
change. At 16W pti the number of myelinated axons was reduced by 46% compared to 
controls and at 26W and 40W pti by 80%. This suggests that most myelin sheaths belonging 
to recombined oligodendrocytes were shortened or have vanished by 26W pti. The 
remaining myelinated profiles likely belong mostly to non-recombined oligodendrocytes. A 
linear regression of the density of myelinated axons in the optic nerve for time points 8W 
(100%), 16W (54%) and 26W (20%) (y = - 4.604*X + 137.5) was calculated. Extrapolating 
from this regression we found that a level of 50% of myelinated profiles compared to 
controls is reached around 19W or 133 days pti. Using FIB-SEM 3D Data we found the 
coverage of individual axons to be approximately 72% at 16W compared to 96% in controls 
and 28% at 26W compared to 92% in controls. Based on linear regression (Y = -4,3*X + 
141,8) 50% myelin coverage was reached approximately 21 weeks or 147 days pti. These 
approximations suggest that the loss of MBP synthesis results in shortening of myelin 






(A)3D reconstruction of a 26W pti optic nerve volume acquired by focused ion beam scanning electron 
microscopy (FIB-SEM) reveals shortening of internodes and tubule like structures of the observed inner tongue 
phenotype. Non-compact myelin tubules (yellow arrowhead), reconstructed axon (white asterisk). (C) The 
percentage of myelin covered axonal length decreases after MBP iKO to approximately 75% at 16W pti and 30% 
at 26W pti. Quantification of one 3D volume per animal at 16W pti (N=2, animals) and 26W pti (N=1, animals) 
with >90 axons per animal. (B) Transmission electron micrograph analysis of optic nerve reveals a decrease in 
profiles of normally myelinated axons that reflects the internodal shortening as seen in C. Analysis was 
performed on cross sections in the retinal part of the optic nerve of at least 5 random sampled micrographs with 
a total area of> 330 µm² and > 200 axons. N= 3-4 animals (parts of the data are already used in Figure 3-10), 
scale bar 2 µm. 3D data acquisition was performed by Dr. Anna Steyer, electron microscopy core unit, Max-
Planck-Institute for Experimental Medicine.  
 
3.16 Non-compact membrane tubules appear preferentially at the 
juxta-paranode 
To localize sites of myelin turnover within a myelin sheath is challenging and requires 
appropriate means of visualization and ultrastructural resolution. The mouse line used in 
this thesis allows the visualization of the absence of MBP by the lack of myelin compaction. 
Since we found membrane tubules at the inner tongue of the myelin sheath by thin section 
EM analysis, we aimed to determine the site of emergence of the membrane tubules within 
a myelinated internode. We assume that the tubules are the result of continued membrane 
synthesis of the intact oligodendrocyte and therefore indicate the site of active membrane 
insertion into the myelin sheath. To achieve this, 3D FIB-SEM microscopy of high pressure 
frozen and freeze substituted optic nerve 16W pti was performed. The preparation by high 
pressure freezing and freeze substitution allows the visualization of the observed 
membrane structures close to the native state by minimizing fixation and dehydration 
artefacts (Schertel et al., 2013). 3D representation and reconstruction of an exemplary axon 
(purple) revealed an accumulation of membrane and non-compact myelin tubules (orange) 
(Figure 3-31, A 3.5 µm) as well as axonal deformation (Figure 3-31, A 2.5µm) at the juxta-
paranode close to the node of Ranvier (Figure 3-31, A 0 µm). Approximately in 10 µm 
distance from the node of Ranvier into the internode no membrane accumulation was 
observed (Figure 3-31, A, 12.5 µm). This phenotype is also observed in longitudinal sections 
of high pressure frozen optic nerve (Figure 3-31,B). We conclude that the emergence of 
shiverer-like membrane tubules at the juxtaparanode induces the “myelin stack” formation, 
internode shortening and subsequent impairment of the nodal structure. In accordance the 
number of functional node of Ranvier as quantified by labeling of focally enriched NaV 1.6 
ion channels flanked by contactin associated protein 1 (CASPR1) is significantly reduced in 
optic nerve 16W and 26W pti (Figure 3-31, C). 






(A) Segmentation of a myelin internode reveals that a massive accumulation of non-compact tubules occur 
predominantly at the juxta-paranode (1,5-3,5 µm) while the same axons seems unaffected further along the 
internode (12,5 µm) (High pressure frozen and freeze substituted optic nerve 16W pti.). (B) High resolution 
visualization of the juxta-paranodal phenotype on transmission electron micrographs of a longitudinal sectioned 
juxta-paranodal region reveals large amounts of non-compact membrane and detachment of paranodal loops 
close to the node of Ranvier  (High pressure frozen and freeze substituted optic nerve 26W pti) (C) The loss of 
functional nodes of Ranvier as demonstrated by loss of NaV 1.6 and CASPR1 signal can be observed 16W and 
40W pti. (confocal images of longitudinal optic nerve cryosections N= 3-4 animals, two‐tailed unpaired t‐test. 
p < .05 (*), p < .01 (**). Scale bar 100 nm (A) 500 nm (B) and 10 µm(C) (Data acquisition by FIB-SEM was 
performed by Dr. Anna Steyer, Electron microscopy core unit Max-Planck-Institute for Experimental Medicine). 
 
3.17 Increase in myelin spheres at the inner tongue  
As shown above, the internodal shortening can be explained by the insertion of MBP-free 
membrane tubules and the loss of axo-glia interaction at the paranode. These tubules are 
representing myelin renewal. For the observed thinning of the myelin sheath removal 
mechanisms must play a role. Myelin removal during aging and demyelination is partially 
mediated by uptake trough astrocytes (Ponath et al., 2017) and microglia (Safaiyan et al., 
2016). In our model of genetic demyelination we found long myelin outfoldings (Figure 
3-32, A, A’) and myelin debris close to and in astrocytic processes (Figure 3-32, B, B’). Also 
microglial are found in direct contact to myelin protrusions and non-compact myelin 
membrane. The presence of dark degradative compartments containing myelin debris show 
microglial uptake of myelin (Figure 3-32, C, C’). Beside myelin removal by astrocytes and 
microglia, the shedding of myelin spheres (Hill et al., 2018) or Marchi bodies (Hildebrand 
and Aldskogius, 1976; Persson et al., 1992) are discussed as a mechanism of myelin 
disposal.  
When analyzing our mouse model, a progressive decrease in myelin thickness as measured 
by corrected g-ratio in optic nerve was observed at 16W and 26W pti as described above 
(Figure 3-12, C, D and Figure 3-33, A). At the same time an increased number of myelin 
spheres at the inner tongue of oligodendrocytes was found. These structures resemble 
compact myelin membrane that is either unconnected or only partially connected to the 
myelin sheath (white arrow head in panel (e)) (Figure 3-33, B). These myelin spheres are 
localized in the inner tongue along the axon and appear in control as well as iKO animals 
(Figure 3-33, C, D). Using 3D FIB-SEM volume imaging the abundance of myelin spheres per 
µm axonal length was quantified and found to be significantly increased in optic nerve 16W 
and 26W pti (Figure 3-33, D). Since the observed myelin spheres are a rare event and due 
to a limited 3D volume that did not always cover complete internodes, most analyzed axons 
were lacking myelin spheres. To perform a statistical analysis the data from 16W and 26W 
were pooled and displayed as averages of individual animals revealing a significant increase 
in the number of myelin spheres per µm axonal length (Figure 3-33, E).  
 




(A, A’) Myelin outfoldings (white arrow head) are detectable and significantly increased. (B-B’) Astrocytes (AS) 
are found in direct contact to myelin protrusions (red arrow head). (C-C’) Microglia (false colored in green) are 
found close to demyelinating axons (Asterisk) and non-compact myelin membrane (false colored in orange). 
Presence of dark degradative compartments (Cantuti-Castelvetri et al., 2018) containing myelin debris show 
microglial uptake of myelin. Images were extracted from a FIB-SEM volume of optic nerve 26W pti, scale bar 1 
µm. 
 






 (A) G-ratio measurements corrected for inner tongue enlargement by subtraction of inner tongue area from the 
complete fiber reveal progressive thinning of myelin sheaths after MBP iKO data also plotted in Figure 3-12 B-
D)(>100 axons per animal, N=3-4 animals). (B) 3D electron microscopy (FIB-SEM) reveals compact myelin 
spheres in the oligodendrocyte inner tongue. (16W pti, high pressure frozen and freeze substituted optic nerve, 
frame a-f cover a z-volume of 330 nm ) (C) Spheres of compact myelin in the inner tongue visualized along an 
axon (optic nerve, 26W pti, K&S fixation (blue: axon, red: myelin spheres)). (D) The number of inner tongue 
myelin spheres per µm axonal length is increased in iKO 16W and 26W pti. on the level of individual axons (D) 
and by averaging the number of myelin spheres per axon per animal (E) Quantification of one 3D volume per 
animal at 16W pti (N=2, animals) and 26W pti (N=1 animal) with >90 axons per animal. Kolmogorow-Smirnow-
Test (A and D) and two‐tailed unpaired t‐test (D) p < .05 (*), p < .01 (**), p < .001 (***). FIB-SEM acquisition was 
performed with the help of Dr. Anna Steyer, Electron microscopy core unit Max-Planck-Institute of Experimental 
Medicine, scale bar 0.5 µm. 
 
The g-ratio along an axon can vary considerably as shown by 3D electron microscopy (Giacci 
et al., 2018). Hence, we decided to investigate a potential link between the thinning of 
myelin and the localization and presence of myelin spheres along an internode. Five 
myelinated axons from control and iKO 26W pti were chosen for analysis. The corrected g-
ratio was measured every µm along the axon and plotted together with the occurrence of 
myelin spheres at the inner tongue (red circle) and myelin outfoldings (green circle) (Figure 
3-34). While the corrected g-ratio is increased compared to control axons no obvious 
association between the number of myelin spheres and changes in corrected g-ratio were 
observed. From these results we conclude that the local occurrence of myelin spheres seems 
to be mostly independent of the myelin thickness at that position. Interestingly, most 
spheres were observed at the inner tongue. These spheres are not accessible to removal by 
microglia or astrocytes. Therefore, we assume that these myelin spheres are indications of 
oligodendrocyte-intrinsic mechanisms of myelin removal and recycling. 




The presence of myelin spheres (red circles) or myelin outfoldings (green circles) have no obvious effect on the 
corrected g-ratio. Corrected g-ratio was sampled every µm. Five axons from control and iKO were measured 
within one FIB volume per condition in optic nerve 26W pti.  
  
Figure 3-34 Visualization of myelin spheres at the inner tongue 
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3.18 Signs of remyelination 52 weeks after knock-out induction 
Since the tremor of knock-out mice showed a peak in severity at 40W pti followed by a 
decline in tremor score we aimed to test for signs of remyelination that could explain the 
decreasing motor impairment. qPCR analysis of Mbp and Plp transcripts at 5 time points for 
brain and 4 time points for spinal cord from 8W to 52W pti were performed and revealed 
significant changes in Mbp and Plp1 mRNA expression. While expression of Mbp mRNA was 
significantly reduced in iKO between 8W and 26W pti it showed a progressive trend to 
increase in both tissues. Comparing knock-out animals 8W pti to knock-out animals 52W 
pti revealed increased Mbp mRNA levels in brain and spinal cord that were no longer 
significantly different from control (Figure 3-35, A, B). For Plp1 the relative expression in 
iKO brain is unchanged between 8W, 16W, 26W and 40W pti and shows a significant 
increase at 52W pti. In contrast the abundance of Plp1 in the spinal cord compared to control 
is significantly decreased at 8W, 16W and 26W and unchanged with a tendency to an 
increase at 52W pti. From the increased Mbp and Plp1 transcript abundance in brain and 
spinal cord at 52W compared to 8W pti we conclude that proliferation of non-recombined 
OPCs and differentiation to oligodendrocytes as well as remyelination has occurred.  
Next, we assessed sings of remyelination in the optic nerve of animals 52W pti. Optic nerves 
were separated in a proximal/chiasmal and a distal/retinal part and corrected g-ratios were 
obtained (Figure 3-36). It is known that remyelinated axons in the CNS have thinner myelin 
which is reflected in an increased g-ratio (Blakemore, 1974). We found increased corrected 
g-ratios in proximal (Figure 3-36, D) and distal (Figure 3-36, C) optic nerve as reflected in 
an upshift in the cloud of corrected g-ratios compared to control. We compared corrected 
g-ratio change to control and found it to be higher in the distal part compared to the 
proximal part of the optic nerve. Hence, we concluded that remyelination was going on in 
the optic nerve 52W pti and due to the presence of compact myelin and Mbp transcript in 
brain and spinal cord has been generated by newly formed non-recombined 




Mbp mRNA is strongly reduced in brain (A) and spinal cord (B) after knock-out induction. Abundance of Plp 
mRNA in Brain is unchanged 8W to 40W pti. but consistently decreased in spinal cord. Despite the loss of Mbp 
mRNA in adult oligodendrocytes, the levels of mRNA increase between 26W and 52W pti in brain and spinal 
cord (A-B) which together with increased levels of PLP 52W pti is indicative for maturation of newly formed 
mature oligodendrocytes (C-D) q-PCR analysis of total brain and spinal cord, N=4 animals, two‐tailed unpaired 
t‐test; p < .05 (*), p < .01 (**), p < .001 (***). 




(A) Electron micrographs show thin myelin sheaths with intact myelin in optic nerve 52W pti. (B) A continuous 
decrease in myelinated axons is observed between 8W and 40W pti while at 52W pti a tendency for more myelin 
profiles can be observed in distal and proximal part of the optic nerve (B). N= 3-4 animals, two‐tailed unpaired 
t‐test; p < .001 (***). (C, D) Corrected g-ratios for proximal (C) and distal (D) parts of the optic nerve 52W pti 
show presence of thinner myelin and a large number of unmyelinated axons with a corrected g-ratio of 1 
compared to control. The number of myelinated fibers is larger in the proximal compared to the distal part. N= 
4-5 animals, >150 axons per animal. Corrected g-ratio measurements were performed by Daniela Doda as part 
of a labrotation, scale bar 1 µm.  
  
Figure 3-36 Remyelination in the optic nerve 52W pti 
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Chapter 4 Discussion  
4.1 Studying myelin turnover  
The central nervous system demands seemingly opposing characteristics from its cellular 
systems: stability and adaptation. On the one hand neurons as well as glia require a high 
level of plasticity to enable learning and timely adaptation to challenges like injury. On the 
other hand neurons (Morrison and Hof, 1997; Magrassi et al., 2013) as well as 
oligodendrocytes (Yeung et al., 2014; Tripathi et al., 2017) are very long lived and need to 
provide stable pathways that facilitate memory formation and connectivity. For 
oligodendrocytes this means consistent myelination, inhibition of axonal sprouting (Huang, 
2005) and metabolic support to axons (Fünfschilling et al., 2012; Saab et al., 2016). The fact 
that myelin itself is a highly stable structure is reflected in the long protein life-time of the 
major myelin proteins (Fornasiero et al., 2018) and lipids (Ando et al., 2003).  
However, despite the life time of these proteins in the range of weeks to months, the myelin 
sheath requires maintenance by replacement of aged and dysfunctional proteins. Studies of 
human oligodendrocytes have shown that the cells survive up to 50 years but that the 
myelin compartment is undergoing a much faster turnover (Yeung et al., 2014). Due to the 
dense structure of the compact myelin which excludes most cytosolic proteins (Aggarwal et 
al., 2011b) it is difficult to conceive how proteins are removed and replaced to allow 
turnover.  
To study myelin maintenance and turnover in the adult animal an inducible model system 
is required that allows to investigate integration and removal of myelin components at an 
age when developmental myelination is completed and the transition to adult levels of 
myelin turnover and maintenance has happened. Necessary requirements for such a model 
system include survival of oligodendrocytes, ongoing steady-state synthesis of myelin genes 
and limited levels of inflammation. 
Currently available models to study myelin turnover and maintenance are based on rather 
invasive manipulation of oligodendrocytes like inducible ablation of the myelin 
transcription factor MYRF (Koenning et al., 2012) or inducible expression of diphtheria 
toxin (Traka et al., 2010) which are both so impairing that they lead to oligodendrocyte loss. 
These models only allow to study changes in oligodendrocyte population but are less 
informative in understanding the steady state turnover within living oligodendrocytes. 
Other models that affect myelin are toxin-induced demyelination models like the 
application of cuprizone (Torkildsen et al., 2008) or lysolecithin (Woodruff and Franklin, 
1999; Plemel et al., 2018) and immune mediated demyelination models such as EAE 
(Kornek et al., 2000). These also lead to oligodendrocyte death and massive inflammation 
and therefore model acute demyelination rather than the steady state turnover.  
Another model used to study myelin turnover is an inducible adult PLP knock-out which 
was recently published (Lüders et al., 2019). The ablation of Plp synthesis in the adult 
animal resulted in increased number of myelin outfoldings, lamellae splitting and axonal 
spheroids 10 months after knock-out induction. This showed that continuous PLP 
expression is required for preservation of white matter integrity (Lüders et al., 2019). 
However, despite the appearance of myelin pathology due to lack of proper myelin 
maintenance by loss of PLP expression, this model does not allow to differentiate between 
aged and newly synthesized myelin by localized ultrastructural changes. In comparison to 
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this, the Mbpflox/flox*PlpCreERT2 model allows the visualization of myelin turnover at the age of 
up to a year. 
Moreover, new advanced imaging tools like volume imaging by focused-ion-beam scanning 
electron microscopy (FIB-SEM) allow now to study myelin structure not only on thin section 
level, but also in three dimensions. Such an analytical approach, together with a mouse 
model that meets our criteria provided all the tools we need to gain a deeper understanding 
of such a basic but also enigmatic process like myelin maintenance.  
 
4.2 A new mouse model to study adult myelin turnover 
To address aspects of myelin turnover by fine structural analysis a mouse model was 
developed to visualize evidence for turnover in adulthood. The Mbpflox/flox*PlpCreERT2 
tamoxifen-inducible mouse line described in this thesis makes use of the compacting 
function of myelin basic protein (MBP) to determine the sites of membrane insertion within 
individual mature myelin sheaths. We assumed that newly synthetized myelin membrane 
after the induced knock out of MBP will lack compaction. The localization of such structural 
changes along the internode was then achieved by 3D FIB-SEM volume imaging and high-
resolution transmission electron microscopy.  
Ablation of MBP synthesis was performed at 8 weeks in young adult animals when 
developmental myelination in the brain is considered to be mostly complete (Baumann and 
Pham-Dinh, 2001) and MBP levels stabilized (Delassalle et al., 1981). The time window for 
the completion of myelin is currently under debate. Recent studies have questioned the 
completion of myelination at that the age of 8 weeks (Young et al., 2013; Tripathi et al., 
2017). Young and colleagues found oligodendrocyte proliferation rates in the nearly fully 
myelinated optic nerve at 4 months of age that exceeded the rate expected for first-time 
myelination of naked axons (Young et al., 2013). They suggested that newly differentiated 
cells might be involved in replacing aged oligodendrocytes. A recent study by Tripathi and 
colleagues measured oligodendrocyte densities in different CNS tracts between P70 and 
P605. They found an increased density of CC1+ cells in the corpus callosum between P150 
and P605 while the density in spinal cord decreased. In the optic nerve the cell number 
decreased between P70 and P90, then increased between P180 and P365 before decreasing 
again between P425 and P605 (Tripathi et al., 2017). These data show ongoing 
oligodendrogenesis and remodeling in the different CNS tracts on the level of 
oligodendrocyte population after P60.  
However, the induced ablation of MBP in our model takes place only on the level of mature 
oligodendrocytes and not OPCs. This is validated by the presence of remyelination within 
one year after knock-out induction. We therefore argue that we only targeted cells that 
actively express myelin genes including Plp and have already laid down their myelin sheaths 
during the first 60 days of life while cells differentiated after tamoxifen injection are not 
affected. It currently remains unknown whether the myelin produced until P60 is different 
from myelin produced at e.g. one year. Also, ongoing maturation and changes of the myelin 
sheath remain possible. Our own proteome data in the department (personal 
communication Dr. Hauke Werner) reveal that age dependent changes in myelin 
composition are likely. Validation of these age-related differences are of interest and 
currently under investigation.  
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To understand the kinetics of MBP and myelin decay in our mouse model it is important to 
assess the mRNA half-life of Mbp transcript. It is known that Mbp mRNA is packed into RNA 
granules and that these are enriched in the compact myelin fraction (Colman et al., 1982; 
Kristensson et al., 1986; Ruskamo et al., 2014) where local translation is triggered by 
phosphorylation of ribonucleoprotein A2 by Fyn kinase (White et al., 2008; Torvund-Jensen 
et al., 2014). Due to the packaging into granules the Mbp mRNA is most likely more stable 
compared to the mRNA of other myelin genes that are expressed in the soma and 
transported as proteins. Studies of Plp and Mbp mRNA stability in brain slices have shown 
that the mRNA half-life of Plp is around 5 hours while the Mbp mRNA is stable for more than 
12 h (Mathisen et al., 1997). We therefore investigated the MBP decay after knock-out 
induction. After tamoxifen treatment the abundance of Mbp mRNA reached the level of 
approximately 40 % of control within 20 days after the first injection. This was the maximal 
achieved reduction showing that most Mbp mRNA has decayed in recombined cells, since at 
later time points comparable expression levels were detected. Remaining mRNA can most 
likely be attributed to non-recombined oligodendrocytes. This shows that already the MBP 
mRNA is stable for several days but reached the baseline level at a time point which we 
consider 0 weeks after tamoxifen.  
Other myelin genes such as Mag, Mog or Cnp were not affected by the loss of Mbp expression 
which is evident for ongoing myelin synthesis. Increased oligodendrocyte density and low 
levels of apoptotic cells in fimbria together with persistent low levels of Mbp transcript in 
the brain are indicative for the survival of the recombined oligodendrocyte. Widespread 
loss of oligodendrocytes would reduce the levels of myelin gene transcripts as for example 
described after adult ablation of myelin regulatory factor (Koenning et al., 2012). 
Immunohistochemistry of neuropathological markers in brain and spinal cord at 8 and 16W 
pti has shown low levels of astrogliosis and microgliosis compared to demyelinating models 
characterized by strong inflammation such as cuprizone (Hibbits et al., 2012) or EAE 
(Benveniste, 1997). While the levels of inflammation are low, ultrastructural changes of the 
myelin sheath are observed already at 8W pti. These observed membrane structures at the 
inner tongue appear to be similar to oligodendrocyte processes seen in shiverer mice 
(Rosenbluth, 1980; Möbius et al., 2016). The emergence of this phenotype at such an early 
time point before the onset of gliosis allows us to study aspects of myelin turnover in a 





4.3 Adult myelin turnover – Insertion of new membrane 
Turnover implies the exchange of old material by newly synthetized molecules, which 
integrate into the existing structure. We could visualize by structural analysis that after Mbp 
ablation the fully developed myelin sheath is slowly and progressively transformed into a 
shiverer-like phenotype. We hypothesize that this transition happens from inside-out by 
adaxonal insertion of newly synthetized non-compacted membranes predominantly at the 
juxtaparanode. The inner tongue at the juxtaparanodal region was enlarged and filled with 
numerous membrane tubules. The increased occurrence of tubules towards the 
juxtaparanode implies that the differing amounts of membrane tubules and inner tongue 
enlargement previously observed by thin section analysis depends on the distance to the 
node of Ranvier. Only electron microscopic volume imaging and 3D analysis provided the 
context for fully understanding the spatial characteristics of this phenotype. 
It is also conceivable that MBP is selectively removed from myelin membranes at these sites 
of observed structural changes and that this tubulation is induced by local MBP loss as 
described in acute demyelination (Weil et al., 2016). Several findings in our study speak 
against this possibility: In models of acute demyelination oligodendrocyte death and the 
concomitant rise in intracellular Ca2+ levels induce a conformational change of MBP that 
causes dramatic myelin decompaction. Such a scenario could be excluded in our mouse 
model by the lack of according pathology and the very slow development of the membrane 
phenotype over weeks and months. Furthermore, ongoing synthesis of Plp, Mag, Mog and 
Cnp in the brain as well as isolated oligodendrocytes indicates ongoing myelin gene 
expression in recombined oligodendrocytes. The expression of genes associated with 
cholesterol synthesis are not reduced in isolated oligodendrocytes including the rate 
limiting enzyme for cholesterol synthesis (Hmgcr) and the enzyme responsible for the first 
committed step of cholesterol synthesis (Fdft1). On the tissue level, some of the analyzed 
cholesterol synthesis genes are reduced likely because of a reduction of cholesterol 
synthesis in other cell types such as neurons, microglia or astrocytes. Astrocytes are 
believed to be main producers of cholesterol in the brain (Pfrieger and Ungerer, 2011) and 
could potentially reduce their de novo cholesterol synthesis in response to recycling of 
myelin membrane under demyelinating conditions. While a slight reduction in cholesterol 
lipid abundance is observed in the optic nerve 8W pti. This minor decrease is probably 
reflecting the loss of the compact myelin compartment and not a reduction in cholesterol 
synthesis. However, this evidence for continuous myelin protein and lipid synthesis by 
recombined oligodendrocytes supports the idea that the emerging tubules represent newly 
integrated myelin membranes and not a phenotype of local removal of aged MBP. 
Since the shiverer-like membrane tubules appear predominantly at the inner tongue and the 
juxtaparanode we propose that these are metabolically active sites within the myelin sheath 
where myelin turnover takes place. Myelin membrane integration during development also 
takes place at the inner tongue (Snaidero et al., 2014) and membrane turnover has been 
hypothesized to happen at the paranode (Arancibia-Carcamo and Attwell, 2014). It is 
therefore conceivable that myelin integration during turnover takes place at the same sites 
as during development. 
We propose that non-compact membranes observed at the inner tongue and the juxta-
paranode are newly formed myelin membranes that in the absence of MBP are not able to 
compact and become part of the myelin sheath. Unequivocal direct evidence for the local 
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integration of new myelin proteins at these sites into the adult myelin sheath could be 
obtained by pulse chase isotopic labeling followed by Nanoscale Secondary Ion Mass 
Spectrometry (NanoSIMS). Such experiments are currently ongoing. 
 
4.4 MBP loss and the half-life on an internode 
Turnover also implies removal of aged material. In our model the MBP which was 
synthetized and integrated into the myelin sheath during development is slowly lost from 
the system. To investigate whether MBP is diluted out of the myelin sheath we analyzed its 
lateral mobility within compact myelin. The lack of MBP mobility was determined by 
biochemical as well as immunoelectron microscopic evidence. We showed that in the iKO 
the mass of the isolated myelin fraction from brain lysate was reduced but contained 
wildtype levels of MBP. Accordingly, the labeling density of MBP on thin cryosections of iKO 
animals was the same on compact myelin compared to controls, but the total area of 
compact myelin was reduced. This evidence confirms that the compact myelin 
compartment is strictly defined by the presence of MBP (Kimura et al., 1989; Readhead and 
Hood, 1990). Furthermore, this result implies that due to the lack of lateral mobility MBP is 
not removed by dilution out of the myelin sheath. However, in contrast to MBP, myelin lipids 
have a high lateral mobility (Ando et al., 2003). 
How is MBP then removed and replaced within compact myelin? Possibilities include 
increased levels of calcium influx leading to conformational changes of MBP and local 
opening of myelinic channels (Weil et al., 2016) followed by calcium dependent proteolysis 
by cathepsin D, as suggested by in vitro experiments (Banik et al., 1985). Another proposed 
mechanism involves citrullination of MBP by the myelin localized peptidyl arginine 
deiminase 2 (PADI2) which induces a reduction in MBP charge and conformational changes 
resulting in detaching from membrane, local decompaction and subsequent recycling 
(Moscarello et al., 2007; Wood et al., 2008). It is possible that these mechanisms of selective 
MBP removal are involved in the myelin turnover happening at the edges of compact myelin 
which are facing the non-compact myelin compartment. These questions remain to be 
addressed. 
In our model we see direct consequences of MBP depletion in the form emergence of myelin 
tubules while at the same time physiological processes of myelin removal are continuing to 
take place. The emergence of non-compact myelin membrane is a direct result of lacking 
MBP and correlates with progressive loss of myelinated profiles in different CNS fiber tracts. 
Decreased density of myelinated axons in the optic nerve, caudal corpus callosum and the 
corticospinal tract of the spinal cord show that the loss of compact myelin takes place in all 
analyzed parts of the CNS. The kinetics of myelin loss as measured by the density of 
myelinated axons per µm² was not uniform in all these tracts. For example, the density of 
myelinated axons reached a minimum at 26W pti in the optic nerve compared to 52W pti in 
the spinal cord. This might be due to differences in internodal length between CNS fiber 
tracts (Hildebrand et al., 1993; Bechler et al., 2015). Assuming that long internodes in the 
spinal cord (Friede et al., 1981; Bechler et al., 2015) are lost with a comparable speed than 
shorter internodes in the optic nerve, a decrease in myelinated profiles could appear later 
or be less pronounced in the spinal cord. 
Quantification of myelinated and unmyelinated axons as fractions of total axon number in 
the optic nerve revealed a progressive decrease in myelinated axons and a corresponding 
increase in unmyelinated axon in the absence of axonal degeneration. To better understand 
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the loss of myelinated profiles we performed 3D FIB-SEM analysis and found that many 
axons had reduced myelin coverage after ablation of MBP synthesis. Although the imaged 
internodes were mostly not completely contained in the volume, we obtained direct 
evidence for shortening of internodes. The 3D visualization revealed non-compact myelin 
membranes as well as detachment of paranodal loops at the edge of these internodes 
suggesting shortening by retraction from the node of Ranvier (Figure 4-1).  
 
Presence of non-compact membrane tubules (orange) and detachment of paranodal loops (red arrow heads) 
from the axon (purple). HPF, Transmission electron micrograph of longitudinal optic nerve 26W pti, scale bar 
1 µm. 
 
The comparison of reduced myelin coverage determined by 3D analysis and the reduced 
number of myelinated profiles on cross-sections yielded similar results. Therefore, the 
counting of myelinated profiles on cross-sections provides a valid estimate to quantify 
internodal shortening. Using the density of myelinated axons on a cross section of the optic 
nerve, we estimated that it takes 19-21 weeks (133-147 days) until 50% of the myelin 
profiles were lost. This also corresponds to the time it takes to shorten an internode by half, 
thereby describing the half-life of an internode in our model in the optic nerve. We found 
that the myelin sheath is a highly stable structure with a half-life of 4 to 5 months, which we 
have determined by preventing the renewal of compact myelin and measuring its decay. 
With this genetic tool we could observe the half-life of a complete structure which can 
deviate from the half-life of its components. 
Figure 4-1 Indications for internodal shortening including paranode retraction  
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The stability of myelin has been addressed in several studies that quantified the half-life of 
individual myelin proteins in the brain (Sabri et al., 1974; Savas et al., 2012; Toyama et al., 
2013; Fornasiero et al., 2018). The components of the myelin sheath were frequently found 
belonging to the most long-lived proteins beside histones and nuclear pore in brain 
(Toyama et al., 2013; Fornasiero et al., 2018). The most recent publication by Fornaserio 
and colleagues used sophisticated reutilization models to calculate precise half-lives of 
myelin proteins from different brain regions. MBP has been found to have a half-life 
between 82 days in cortex and 70 days in a special long pulse experiment designed for 
proteins with a long half-life. Also other myelin proteins have very long half-lives like PLP 
(80 days), tetraspanin-2 (90 days), MOG (164 days) and claudin-11 (139 days) (Fornasiero 
et al., 2018). In contrast CNP has a half-life of around 53 days being a rather short-lived 
myelin protein and the only non-compact myelin protein the authors selected for 
comparison. The average half-life of the compact myelin proteins listed here is about 109 
days reflecting the high stability of the myelin sheath. We calculated an MBP half-life of 
approximately 77 days which is in close agreement with the previously published 70-82 
days (Fornasiero et al., 2018) A study by Toyama and colleagues found that after a chase of 
6 months 20% of initially labeled MBP was still present (Toyama et al., 2013). This is 
comparable to the 25% remaining MBP that was found in our model 26 weeks post 
tamoxifen induction. The remaining difference might be explained by presence of MBP from 
non-recombined and newly differentiated oligodendrocytes.  
However, looking at the structure of the myelin sheath we have found that the half-lives for 
PLP, MBP and tetraspanin-2 in the brain are shorter than our estimation of 133-147 days as 
half-life of the complete myelin sheath in the optic nerve. An explanation could be that 25% 
expression of Mbp mRNA is sufficient to form compact myelin (Readhead et al., 1987), also 
heterozygous shiverer mice that have 50-70% of MBP protein compared to control have 
functional and normal appearing compact myelin (Poggi et al., 2016). Even with decreased 
levels of MBP in compact myelin, for example by MBP removal due to limited lateral 
mobility, the myelin membrane could still be compact and functional. Additionally, the 
observed thinning of compact myelin could also contribute to MBP loss without necessarily 
affecting internodal length. 
The observed changes in internodal length in our model could partially reflect a 
physiological mechanism of myelin remodeling. Life imaging experiments on zebrafish have 
shown sheath elongation and retraction as physiological process during development 
(Czopka et al., 2013) and chronic imaging of myelin internode in the mouse cortex shows 
changes in internode length (Hill et al., 2018). Growth and shrinkage of internodes albeit 
without the observed loss of paranodal adhesion to the axon in this model could be a way 
for mature oligodendrocytes to remodel their myelin sheath.  
In conclusion, we find that continuous synthesis of MBP is required to maintain myelin 
internodes as well as nodes of Ranvier. Absence of MBP results in shortening of internodes 
and loss of node structure by progressive demyelination. Here, we identify the paranodal 
and juxta-paranodal region, first affected by loss of MBP synthesis, as an important site for 





4.5 Myelin removal by oligodendrocytes 
As described above the decrease in MBP abundance in brain lysates suggests a faster loss of 
MBP than expected from internode shortening alone. The increase in corrected g-ratio in 
the optic nerve at 16W and 26W pti indicates also a reduction in myelin thickness. This loss 
of compact myelin by shortening of internodes together with thinning of compact myelin 
might reflect the consequences of the observed loss of MBP protein abundance more closely. 
Since MBP-dilution was shown to be less plausible as a mechanism of MBP turnover due to 
lacking lateral mobility, more likely compact myelin as a whole undergoes removal. In 
principle two different routes of removal could be followed. Intracellular removal by the 
oligodendrocyte or extracellular removal by other cells like astrocytes and microglia. 
Microglia (Safaiyan et al., 2016) as well as astrocytes (Mills et al., 2015; Ponath et al., 2017) 
are implicated in removal of myelin during aging or demyelination. Especially astrocytes 
that can form direct contact at the node of Ranvier (Butt et al., 1994) and might be involved 
in active uptake of myelin. Accordingly, we have observed microglial uptake of myelin 
debris as well as myelin protrusions into astrocyte processes in our 3D data.  
In addition to these events, the 3D FIB-SEM data of control and iKO mice revealed the 
presence of myelin membrane structures at the inner tongue and outside of compact myelin. 
These compact myelin spheres have previously been described as myelin spheroids in aged 
brains of rhesus monkeys (Peters and Sethares, 2002) or as Marchi Bodies found in normal 
white matter (Hildebrand and Aldskogius, 1976) often localized close to the paranode 
(Corneliuson et al., 1987). Compact myelin spheres at the inner tongue called myelinosomes 
were also recently described as an early stage of myelin damage in EAE lesions where they 
were actively taken up by macrophages (Romanelli et al., 2016). A recent life imaging study 
found increased numbers of myelin spheres during aging and could follow the formation 
and degradation of these structures showing that generation and removal can take several 
weeks (Hill et al., 2018). 
We found compact myelin spheres predominantly at the inner tongue of control as well as 
iKO animals 16W and 26W pti. Using FIB-SEM acquisition with a high XY (5 nm pixel size) 
and Z (10 nm step size) resolution we could identify also smaller myelin spheres as 
infrequent evens of control animals. This finding suggests that myelin spheres are present 
not only during demyelination but also under normal conditions. Since these myelin 
spheres at the inner tongue are rare, they were probably overlooked or mistaken as an 
artefact by conventional electron microscopy on thin sections. Only 3D electron microscopy 
data analysis revealed that these spheres are connected to the myelin sheath. Myelin 
spheres were present independent of the direct presence of microglia or astrocytes 
contacting the myelin sheath and significantly increased in number in iKO mice. Although 
the local thinning of the myelin sheath was not found to be directly associated with the 
presence of myelin spheres at the inner tongue I think that they represent an 
oligodendrocyte-intrinsic removal mechanism of aged myelin. Since these structures are 
also found in normal white matter it is likely that they resemble a cell-intrinsic mechanism 
independent of demyelination. This is supported by knock-out of the autophagosomal 
marker Atg7 (Arakawa et al., 2017) in oligodendrocytes. Ablation of the autophagosomal 
machinery in mice results in increased myelin thickness at the age of 16 months suggesting 
an involvement of autophagy on myelin maintenance (Aber, 2018). 
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4.6 Systemic response to ablation of MBP synthesis 
To investigate the systemic response of MBP loss on the myelinating system we performed 
proteome analysis of whole optic nerve at early and late time points and from shiverer mice 
at an age of 10 weeks for comparison with a model completely lacking MBP. Time points 
8W and 16W pti were included to observe the systemic response to ablation of MBP 
synthesis under low levels of inflammation in a mostly unperturbed system. The 40W pti 
time point was included to investigate a late inflammatory state of ongoing compact myelin 
loss at the peak of symptoms.  
Changes in protein abundance in optic nerve 8W and 16W pti included reduced levels of 
myelin proteins (MBP, PLP, CD9, Opalin) which probably reflected the loss of compact 
myelin compartment by internode shortening and reduction in myelin thickness. On a tissue 
level, lipid synthesis proteins such as CGT (only identified in 8W pti) involved in 
galactocerebrosides synthesis and FPPS (FDPS) (identified in all time points) required for 
cholesterol synthesis were reduced in abundance. In contrast, mRNA expression data of 
isolated oligodendrocytes showed no overall changes in cholesterol synthesis genes 
including FPPS (FDPS). A similar effect was observed in a transcriptome analysis of shiverer 
where cholesterol synthesis genes were reduced in shiverer brain but unchanged in isolated 
and cultured shiverer oligodendrocytes (Aaker et al., 2016). Since FPPS (FDPS) is also 
expressed in astrocytes (Zhang et al., 2014) we believe that reduced levels can be attributed 
to changes in astrocytic cholesterol synthesis due to uptake of cholesterol rich myelin 
debris. 
Another class of proteins reduced in abundance are tetraspanins and cell adhesion 
molecules (TSN2, Protein 4.1, CD81, NCAM1). Since these are also major myelin proteins 
(Jahn et al., 2009) their abundance could be decreased by loss of compact myelin. CD9 and 
CD81 are also involved in Schwann cell to axon interaction (Chernousov et al., 2013) and it 
could be possible that the same proteins are involved here in the loss of oligodendrocyte-
to-axon adhesion during internode retraction.  
Proteins increased in abundance in the optic nerve 8W and 16W pti were associated with 
lipid transport (APOE, APOD) and the cytoskeleton (ARF2/3, fascin and tubulin). In the PNS 
Apod mRNA is upregulated up to 500 fold during de- and remyelination (Boyles et al., 1990) 
and was suggested to be involved in clearance and recycling of myelin debris (Muffat and 
Walker, 2010; García-Mateo et al., 2018). Increased abundance of cytoskeletal proteins 
could be explained by emergence of non-compact myelin membrane tubules. The observed 
structures, in comparison to compact myelin, contained microtubules as seen on the TEM 
images. Another possible explanation is an increased density of axonal microtubules as seen 
in shiverer mice (Kirkpatrick et al., 2001). Due to high levels of protein homology it was not 
possible to resolve individual tubulin species. We therefore cannot distinguish between 
isoforms specific for oligodendrocytes (beta IV tubulin) and axons (beta III tubulin). In 
addition to changes observed at 8W and 16W the 40W pti time point showed a significant 
increase in microglial markers, degradative enzymes (HEXB, CATD, CATZ, CATS) (Zhang et 
al., 2014) and components of the complement system (C1QC, C1CB). This indicated immune 
system activation, inflammation, microgliosis (HEXB) and astrogliosis (AQP4).  
Optic nerves from shiverer had a strong reduction in myelin proteins (MOG, PLP (MPYR), 
CLD11, MAG) as well as cytoskeletal proteins (SEPT2/4, ANLN) likely reflecting the near 
complete absence of compact myelin and therefore reduced levels of all proteins associated 
to compact myelin, as expected. Proteins strongly increased in abundance included 
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ribosomal proteins (60S, RPL4/7a/5) indicating an increased protein translation that could 
be caused by the ongoing effort of oligodendrocytes to form compact myelin and insulate 
axons. Another class of proteins with increased abundance are associated with energy 
metabolism (PGAM2, KCRB, AT1A1). This argues for increased energy requirements in the 
absence of compact myelin (Andrews et al., 2006)  
Complementary to the analysis of the top most affected 30 proteins, pathway enrichment 
analysis of all significantly increased proteins in 8W, 40W pti and shiverer was performed. 
Enrichment of pathways involved in energy metabolism (TCA cycle, glycolysis) in all groups 
suggested an increased energy requirement after the loss of compact myelin. This is 
supported by previously reported increase in mitochondrial size and speed of transport for 
axonal mitochondria after demyelination (Kiryu-Seo et al., 2010). Other enriched pathways 
include the proteasome pathway and phagosomes at 40W pti probably caused by increased 
myelin debris clearing either by microglia or, as discussed, also by oligodendrocytes.  
To summarize, proteome analysis revealed that myelin proteins and cell adhesion proteins 
are reduced while the levels of cytoskeletal proteins and lipid transport proteins are 
increased. As expected, the time points 8W and 16W pti show low levels of inflammation, 
while at the time point 40W pti signs of stronger astrogliosis and microgliosis are detected. 
All observed time points including shiverer show an increase in proteins associated to 
energy metabolism which could reflect the loss of electrical insulation by compact myelin 
and the corresponding higher energy requirements for action potential conduction. 
We performed lipid analysis since we expected major changes in lipid composition of non-
compacted myelin membrane. This was motivated by increased levels of 
phosphatidylserine and cholesterol esters and decreased levels of sphingomyelin, 
phosphatidylcholine and cerebroside sulfates found in white matter lesions of an EAE 
model in marmosets (Ohler et al., 2004) Ohler and colleagues hypothesized that these 
changes lead to increased membrane fluidity and curvature resulting in reduced MBP 
adhesion and destabilization of the myelin sheath (Ohler et al., 2004). 
We investigate changes in lipid composition after emergence of non-compact membrane 
tubules by mass spectrometry analysis in optic nerve and corpus callosum. Focusing on the 
optic nerve 16W pti we found significant increase in phosphatidylinositol (PI) levels. 
Changes in PI signaling have been previously been reported in an pathway enrichment 
analysis in transcriptome of shiverer brain (Aaker et al., 2016). The phospholipid 
phosphatidylinositol 4,5-bisphosphate facilitates stable association between MBP and 
cellular membranes (Nawaz et al., 2013) and phosphorylation of phosphoinositide  
regulates the ability of MBP to bind actin filaments to the membrane (Boggs et al., 2012). PI 
levels are also known to have immunoregulatory effects by limiting proinflammatory 
cytokines and inhibiting the inflammatory T‐cell response in a model of chronic 
inflammation (van Dieren et al., 2011). This suggests that a beginning inflammatory gliosis 
could  also be responsible for the increased levels of PI. The performed analysis did not 
allow distinction between PIP2 and other PIP forms. I speculate that increased levels of PI 
could be a consequence of either the emergence of non-compact membrane tubules or an 
inflammatory response. Additional analysis of PI derivates and lipid composition is 
required to draw further conclusions.  
The lipids phosphatidylglycerol (PG) and lysophosphatidyl choline (LPC) showed a 
tendency for increased abundance without passing the significance threshold in optic nerve 
16W pti but did so in other analyzed time points. Elevated levels of endogenous LPC occur 
after LPC induced demyelination (Plemel et al., 2018). Based on cell culture experiments the 
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authors hypothesized that LPC has a lipid buffer function to ameliorate toxic effects of 
demyelination (Plemel et al., 2018). Elevated levels of PG are associated with inhibition of 
inflammation in a macrophage cell culture model (Chen et al., 2018). Based on these results 
we hypothesize that elevated levels of LPC and PG could be due to a beginning inflammatory 
response to the ongoing loss of compact myelin after ablation of MBP synthesis. We did not 
find comparable changes in lipid composition as reported for whiter matter lesions in EAE 
(Ohler et al., 2004). This further suggests that our model of genetic demyelination is not 
comparable to the immune mediated breakdown of myelin in the EAE mode.  
 
4.7 Late remyelination after MBP ablation 
The observed motor phenotype including tremor and motor impairment as assessed by the 
performed “box test” emerges at 16 to 26W pti. At 26W pti the density of myelinated axons 
is decreased in different myelinating tracts including the spinal cord, but not in the PNS 
indicating CNS pathology. The tremor phenotype peaks between 30W and 40W pti and 
thereafter decreases in severity. Also, the loss of weight decreases in speed, especially in 
female mice. This partial amelioration suggested a compensatory mechanism. 
By analysis of protein expression and morphological assessment of remyelination in the 
optic nerve we found indications of remyelination by newly differentiated OPC which occur 
alongside with recombined oligodendrocytes. This was possible since the used PLP-CreERT2 
driver line allows for recombination of mature oligodendrocytes without affecting OPCs 
(Leone et al., 2003).  
We conclude that remyelination has taken place after ablation of MBP synthesis in adult 
oligodendrocytes. It is however puzzling why remyelination occurred at such a late time 
point. Other models of adult demyelination such as cuprizone (Torkildsen et al., 2008; 
Pfeifenbring et al., 2015) or LPC (Woodruff and Franklin, 1999; Ghasemlou et al., 2007) are 
showing signs of remyelination after days to weeks. Major differences between these 
models and the model used here is the lack of widespread oligodendrocyte death, relatively 
low levels of inflammation and the ongoing presence of myelin debris in form of non-
compact myelin membrane. In multiple sclerosis, the presence of OPCs in a demyelinating 
lesion is not sufficient to induce remyelination, if the environment is inhibitory to OPC 
maturation (Chang et al., 2002). Known inhibitors for OPC differentiation and negative 
regulators of myelination include the presence of PSA-NCAM on axons (Charles et al., 2002) 
the astrocyte generated glycosaminoglycan hyaluron (Back et al., 2005) LINGO-1 as 
expressed on oligodendrocytes (Mi et al., 2005, 2007) and the presence of myelin 
debris(Kotter et al., 2006).  
The survival of recombined oligodendrocytes, which might express inhibitory factors such 
as LINGO-1 (Mi et al., 2009), could prevent maturation of new oligodendrocytes. However, 
in our model the number of CAII+ cells is still increased in the fimbria even at 52W pti due 
to the lack of widespread oligodendrocyte death even at that late time point when 




Increased presence of non-compact myelin tubules and myelin debris at 26W pti might inhibit maturation of 
OPC and remyelination. iKO optic nerve, HPF, scale bar 1 µm.  
 
Another factor known to inhibit remyelination is the presence of myelin debris. Injection of 
myelin after a demyelinating event arrests differentiation of OPCs at a premyelinating state 
(Kotter et al., 2006). It is suggested that phagocytic clearance of myelin debris is affecting 
remyelination (Kotter et al., 2006). Within the first 26W pti we have observed minor levels 
of microgliosis in brain. At 52W pti we saw a striking increase in MAC-3+ cells in the fimbria 
which is indicative for phagocytic activity of microglia probably mediating the uptake of 
myelin debris. Electron micrographs of optic nerve show that at 26W at the beginning of 
remyelination high levels of non-compact myelin membrane are found. In contrast, the 
levels of non-compact myelin membrane (Figure 4-2) are reduced at 52W pti when distinct 
remyelination has taken place. We therefore speculate that the presence of non-compact 
myelin tubules as well as myelin debris might inhibit remyelination and that this inhibition 
is finally resolved after microglial activation and clearance of myelin debris. 
  





Myelin turnover in the adult animal is a crucial process to allow stability and maintenance 
of the myelin sheath once it has been wrapped around the axon. The aim of this thesis was 
to investigate myelin maintenance and turnover by ablating synthesis of MBP in mature 
myelinating oligodendrocytes after completion of developmental myelination. For this, the 
inducible Mbpflox/flox*PlpCreERT2 mouse model was introduced and characterized. Due to its 
low levels of inflammation, the survival of oligodendrocytes after knock-out induction and 
ongoing synthesis of myelin transcripts it fulfills the requirements needed to study myelin 
turnover in the adult mouse. Membrane tubules formed in the absence of MBP and emerged 
at the inner tongue primarily in the juxtaparanodal region, hence this being the likely site 
of myelin membrane insertion and turnover within the myelin internode. Ongoing synthesis 
of MBP was shown to be essential for maintenance of compact myelin. In the absence of 
MBP de novo synthesis the levels of MBP and other compact myelin proteins, the length of 
myelin internodes and myelin thickness decreased progressively. Approximate half 
replacement times of myelin internodes in the optic nerve of 19-21 weeks after ablation of 
MBP synthesis support the assumption that myelin and its components are stable and long 
lived but require replacement within weeks to months. Identification of compact myelin 
spheres at the inner tongue suggests an additional oligodendrocyte-specific mechanism for 
removal of aged myelin besides microglial or astrocytic uptake. This supports the 
hypothesis that myelin turnover is mediated by extracellular as well as intracellular 
mechanisms. The occurrence of remyelination in brain and optic nerve provided evidence 
that mainly adult oligodendrocytes were targeted by tamoxifen-induced recombination 
while OPCs were not. The late onset of remyelination after beginning of the shortening of 
internodes suggests that presence of myelin debris as well as surviving oligodendrocytes 
inhibit remyelination. 
This thesis improves the understanding of myelin maintenance and turnover in the adult 
mouse CNS by providing a new mouse model, which made it possible to localize sites of 
myelin membrane integration and removal within the myelin internode by advanced 
electron microscopic techniques this thesis improves the understanding of myelin 
maintenance and turnover in the adult mouse CNS. The Determination of the mechanisms 
of myelin turnover will increase the understanding of physiological maintenance processes 
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